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Abstract
This study sought to broaden the findings of the current research on the relationship between late
and moderate preterm (LAMP) birth and long-term neurocognitive outcomes—specifically those
related to attention-deficit/hyperactivity disorder (ADHD). The purpose of this study was to
better understand the relationship between gestational age (GA) and ADHD by (a) comparing
prevalence of diagnosis between term-born and LAMP children, (b) comparing ADHD
behavioral symptom severity between term-born and LAMP children, (c) and by examining
neurocognitive status between term-born children and LAMP children (with and without ADHD
diagnoses). The study also examined other factors that contribute to the relationship between GA
and ADHD, including consideration of other risk factors and potential symptom-mitigating
factors. The final sample for this study included 169 patients between the ages of 8 and 12 years
who had completed an outpatient neuropsychological evaluation. GA was not related to ADHD
diagnostic status, but lower GA predicted high ADHD-related symptom severity as indicated by
caregiver report on the Conners-3. Though LAMP children did not differ from their term-born
peers across measures of neurocognitive functioning, lower GA showed a marginally significant
negative relationship with overall neurocognitive functioning (WISC-V FSIQ). Risk factors such
as family history of ADHD and in-utero exposure to substances were consistently significantly
related to ADHD symptom severity, and cumulative risk negatively impacted overall cognitive
functioning, attention, working memory, and executive functioning. Adaptive skills and social
skills were found to mitigate ADHD symptomatology as indicated by caregiver report on the
BASC-3, though total symptom mitigating factors did not influence cognitive outcomes. Lastly,
moderation analyses showed that gestational age interacts with birthweight at a marginally
significant level in predicting overall cognitive functioning.
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Chapter 1: Introduction
Attention-deficit/hyperactivity disorder (ADHD) is the most common disorder of
childhood, affecting 10.2% of children in the United States (US; Carbray, 2018; Xu et al., 2018).
One well known risk factor for ADHD is preterm birth (D’Onofrio et al., 2013). As preterm birth
and ADHD share several risk factors, it is difficult to discern what variance in ADHD
presentation (e.g., symptom severity, subtype, associated neurocognitive deficits) is accounted
for by preterm birth, specifically, and not those shared risk factors. Furthermore, many extremely
preterm and very preterm infants (at/before 25 weeks and 26 to 32 weeks, respectively) are born
with significant medical complications that impact developmental outcomes; these additional
medical complications substantially increase the variance in neurocognitive development, and
therefore obscure the relationship between preterm birth status and ADHD.
By studying ADHD in late and moderate preterm (LAMP) infants (34 to 36 weeks, and
32 to 34 weeks, respectively), it may be possible to gain a clearer understanding of these infants’
course of development and risk for ADHD. Though preterm infants are at substantially increased
risk for developing ADHD, many do not grow up to be diagnosed with ADHD (multifinality)
and many with ADHD do not have a history of preterm birth (equifinality). Therefore, we must
examine risk factors that predict ADHD/ADHD-symptoms following LAMP to better understand
the etiology of ADHD from a biopsychosocial perspective and consequently develop better
interventions. The relationship between LAMP birth and ADHD can best be understood in the
larger context of developmental psychopathology. Therefore, the present review will begin with
a broad discussion of how developmental factors impact psychopathology, before discussing the
specifics of ADHD as an outcome, and LAMP birth as a predisposing risk factor.
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Theory of Developmental Psychopathology
The principle of equifinality refers to nonlinear epigenesis, wherein multiple pathways
can lead to the same outcome (Cicchetti & Rogosch, 1996). Stated another way, children with
different risk and protective factors may arrive at a diagnosis of ADHD. The principle of
multifinality suggests that the effect of an adverse event is dependent on the system in which the
organism lives. The same pathway can result in different patterns of adaption or maladaptation
(Cicchetti & Rogosch, 1996). Therefore, LAMP birth may or may not result in ADHD; the
pathway from predictor/risk factor to outcome is an opportunity for intervention.
The concepts of equifinality and multifinality highlight behavioral and biological
plasticity. Biological and psychosocial factors must be considered in the etiology of a particular
outcome, in this case ADHD. The presence of one factor, such as preterm birth, is not in itself
inextricably linked to the outcome of ADHD, and it may be possible to shift the course of
development through intervention. By examining both ADHD and neuropsychological status as
outcomes, research may be able to identify the totality of attributes associated with risk and other
processes (i.e., symptom-mitigating factors) that shift the pathway between LAMP birth and
childhood psychopathology (i.e., functional impairment)
Psychopathology of Attention-Deficit/Hyperactivity Disorder
ADHD is a high base rate neurodevelopmental disorder of childhood, affecting more than
one in ten children in the US (Carbray, 2018; Xu et al., 2018). There has been a substantial
increase in prevalence within the last two decades (Carbray, 2018) from 6.1% between 1997 and
1998, to 10.2% in 2015-2016 (Xu et al., 2018). The diagnosis of ADHD is based on a child’s
behavioral presentation across two or more settings. Though evaluation of underlying
neurocognitive functioning is not required to make the diagnosis, neuropsychological assessment
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is useful (if not essential) in better understanding a child’s behavioral symptoms and informing
appropriate supports. ADHD-related behaviors may be driven by external factors (environment),
by internal factors (neurocognitive deficits in attention or related systems), or both, and an
understanding of which behaviors can be attributed to which factors informs intervention
strategies.
There are two main symptom dimensions along which a child’s behaviors are assessed:
(a) inattention and (b) hyperactivity/impulsivity (Boada et al., 2014). Meta-analytic research
supports these two separate dimensions (Willcutt et al., 2012). Symptoms of inattention are
characterized by disruptions in sustained attention and failure to attend to stimuli, whereas
hyperactive/impulsive symptoms are characterized by behavioral dysregulation including
disinhibition and motoric overflow. The full diagnostic criteria and examples of symptoms in
each dimension, as taken from the Diagnostic and Statistical Manual of Mental Disorders (5th
Ed.; DSM-5; American Psychiatric Association, 2013) is available in Appendix A. Based on
these symptoms, the ADHD diagnosis is further specified into one of three subtypes: (a)
combined type, (b) predominantly inattentive presentation, and (c) predominantly
hyperactive/impulsive presentation.
There are observed differences among these subtypes. ADHD predominantly
hyperactive/impulsive type has less genetic heritability and a lower prevalence of academic and
cognitive impairments. ADHD combined presentation and predominantly inattentive
presentation have comparable neuropsychological impairment, etiological influences, and
intervention outcomes (Willcutt et al., 2012). Despite the differentiation of subtypes observed in
childhood, they do not have longitudinal stability (Boada et al., 2014). Therefore, when
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considering ADHD as an outcome across development, it may be more helpful to look at ADHD
as a broad diagnostic indicator, rather than attempting to use subtypes.
Long-Term Outcomes. Children with ADHD are more likely to exhibit
underachievement in academics, occupational outcomes, and social functioning (Barkley et al.,
2006; Biederman et al., 2006; Franke et al., 2018; Galéra et al., 2009; Klein et al., 2012). There
are certain prognostic factors that affect the course of ADHD, including long-term outcomes,
symptom severity, and functional impairment. Female children are less likely to be diagnosed
with ADHD, with the ratio of male to female diagnoses around 4:1 (Taylor et al., 2016).
Research has also found gender and age differences in symptom dimensions, with males more
commonly presenting as predominantly hyperactive or combined and females more commonly
presenting as predominantly inattentive (DuPaul et al., 2016). Stress (e.g., family adversity) and
parent disciplinary strategies (e.g., inconsistent parenting) both contribute to long-term outcomes
(Sasser et al., 2016).
Neural Mechanisms of ADHD. There are many different theories of attention in
typically developing individuals. The three main attentional systems proposed by Petersen and
Posner (2012) include the alerting network, the orienting network, and an executive network.
The alerting network includes brain stem arousal systems and right hemisphere systems related
to sustained vigilance (Petersen & Posner, 2012). The orienting network includes the frontal and
posterior areas that help an individual orient toward a prioritized sensory input in the presence of
competing stimuli (winner take all); it also includes the parietal cortex involved in related
processing and distinguishing between sensory versus motor processing (Petersen & Posner,
2012). The executive network involves the frontoparietal and cinguloopercular network. Though
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the orienting network and executive network are distinct, they arise from the same origin in
earlier development (Petersen & Posner, 2012).
In addition to these three systems, distinguished by their function, research supports
another two anatomically and functionally distinct attention systems. There is the dorsal
frontoparietal system, also referred to as the dorsal attention system, and the ventral
frontoparietal system, referred to as the ventral attention system (Corbetta & Shulman, 2002).
The dorsal attention system mediates top-down processes, with voluntary direction of attention
to locations or features. The ventral attention system detects unattended or unexpected stimuli,
helping the individual shift their attention toward the new stimuli. These two systems flexibly
interact to enable a more dynamic control of attention for the purpose of both top-down goals
and attention to bottom-up sensory stimulation (Vossel et al., 2014).
In the case of ADHD, the attentional systems are disrupted. These disruptions are evident
in several regions and networks, most notably in the regions/systems associated with the
prefrontal cortex (PFC). The PFC is the last area of the brain to reach maturation in early
adulthood. However, the infrastructure and networks connected to and communicating with the
PFC begin to develop in-utero. Thus, disruption of the gestational period in LAMP birth impacts
early develop of the PFC networks (Willcutt, 2010), and provide a neural foundational
understanding of how preterm birth may operate as a risk factor for and predictor of ADHD.
The frontal-striatal networks, which include the thalamus, basal ganglia, and dorsolateral
and ventrolateral regions of the PFC have also been widely studied in the ADHD literature
(Willcutt, 2010). This dysfunction can be observed in reduced volume and activation among
individuals with ADHD (Castellanos & Proal, 2012; Cubillo et al., 2012; Durston et al., 2011;
Friedman & Rapoport, 2015; Makris et al., 2007; Ortiz et al., 2015; Seidman et al., 2005;
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Seidman et al., 2006). Dysfunction of the frontal-striatal networks affects response selection,
inhibition, maintenance, manipulation of information, and planning and organization of behavior.
Further, researchers have found that the orbitofrontal cortex may be implicated in the
development of ADHD. More specifically, the orbitofrontal cortex includes those feedback loops
of the ventromedial PFC, limbic structures, and other areas of PFC that play an important role in
decision-making processes (Willcutt, 2010). Primate studies have shown that the ventromedial
PFC neurons activated in prediction/response to reward impact learning and establishment of
behavioral performance (Schultz, 2000). Studies of those with traumatic brain injury have found
that damage to this region results in difficulty associating emotional valence to behavior based
on feedback. Reduced left orbital PFC volume has also been observed among those with ADHD
(Hesslinger et al., 2002). The orbitofrontal cortex and related feedback loops coordinate the
interface between motivation/emotion and cognition, and therefore, damage to this region affects
aversion to delay, learning from mistakes, and monitoring shifts in reward and punishment.
There is also evidence of dysfunction in related neural systems outside of the PFC. It is
important to reiterate that a brain region does not work in isolation; rather, all the regions are
interconnected and work together for functional processing. Persons with ADHD have been
found to exhibit neurological differences in the anterior cingulate cortex, as functional magnetic
resonance imaging (fMRI) studies indicate under-activation (Makris et al., 2007; Ortiz et al.,
2015; Seidman et al., 2006). Functional magnetic resonance imaging (fMRI) is a non-invasive
neuroimaging technique that utilizes changes in blood oxygenation level-dependent contrast as a
measure of neural activity (Huettel, 2017), and provides some evidence for regional patterns of
activity in the brain (Mather et al., 2013). These differences in the anterior cingulate cortex affect
response selection and disrupt the central relay station for top-down and bottom-up processing.

NEUROCOGNITION IN CHILDREN BORN LAMP

7

The dorsal attention system is connected to the PFC and parietal region, and disruptions here
affect associated cognitive processes such as attention and inhibition. The ventral attention
system is connected to limbic structures, and disruptions here affect emotional processes.
The cerebellum has also been implicated as a mediator. Research studies evidence
reduced volume and activation in those with ADHD (Cubillo et al., 2012; Durston et al., 2011;
Makris et al., 2007; Ortiz et al., 2015; Schulz et al., 2004; Stoodley, 2014, 2016). Cerebellar
under-activation affects temporal processes, such as processing speed, response to stimulus, and
reaction time.
Lastly, caudate under-activation has been associated with childhood ADHD (Szekely et
al., 2017). Studies using fMRI have found this deficit particularly pronounced for the right
caudate, and more severe in ADHD combined type than inattentive subtype (Rubia, 2018).
Performance differences have been observed between those with ADHD and controls and are
evident on go/no go tasks (i.e., tests of response inhibition), suggesting that response inhibition is
affected by hypoarousal of the caudate.
Neuropsychological Constructs. There are several neuropsychological constructs
implicated in ADHD. The executive functions, which refer to higher order cognitive processes,
are the most frequently identified neurocognitive deficits (Lezak et al., 2012; Mueller et al.,
2010). The executive functions can be subdivided into more distinct and measurable constructs,
including attention, cognitive flexibility, working memory, and inhibition. Attention, as a
neurocognitive domain, is often subdivided into selective and sustained attention. Selective
attention refers to attending to target stimulus over non-target stimulus (i.e., distractors); this
neuropsychological construct corresponds to the ventral attention system. Sustained attention
refers to continuous performance over time, without significant degradation of performance; it
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corresponds to the dorsal attention system. Sustained attention is different from vigilance, which
implies sustained attention that is specific to threats/dangers. Cognitive flexibility refers to the
ability to switch between tasks without loss of performance. Working memory refers to the
ability to hold and manipulate information in mind. Lastly, inhibition refers to the ability to
suppress actions, including those that are automatic or overlearned, in favor of the desired
response.
In addition to the executive functions, several other neurocognitive domains are impaired
in children with ADHD. Aversion to delay reflects an individual’s desire to decrease the amount
of time spent waiting; it can be conceptualized as an inhibitory control problem or regulative
deficit (Sonuga‐Barke et al., 1992; Willcutt, 2010). It reflects the ADHD symptom dimension of
impulsivity/hyperactivity. Functional analyses of hyperactive children’s impulsivity during
neuropsychological assessment can be understood as a function of delay aversion, both to prereward and post-reward delay, without regard for other economic constraints and reward
conditions (Sonuga‐Barke et al., 1992). In this regard, children with ADHD exhibit a diminished
capacity to modulate their behavior in response to reward and punishment (Willcutt, 2010).
Processing speed has also been found to be diminished in children with ADHD (Shanahan et al.,
2006). Specifically, children with ADHD show greater response precision variability and deficits
in short-duration temporal processing (Mueller et al., 2017; Willcutt, 2010).
Neuropsychological Assessment of ADHD. In keeping with best practice standards
published by the American Academy of Pediatrics (AAP) regarding diagnosis and treatment of
ADHD, a thorough evaluation is a necessary first step toward diagnosing ADHD. Though the
AAP leaves evaluation open to clinical interpretation, cognitive testing is an extremely
informative part of the evaluation, and often necessary to rule out other conditions that may
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better account for attention-related symptoms (e.g., intellectual disability; Achenbach &
Rescorla, 2000). Cognitive testing generally includes an estimate for overall intellectual quotient
(IQ or g), and such measures become stable once children reach school-age (Bartels et al., 2002;
Hoekstra et al., 2007). Notably, attention problems may interfere with a child’s performance on
IQ testing (Schweizer & Moosbrugger, 2004), in which case a clinician must be mindful of the
attentional demands of a particular test, and may have to flexibly administer another test to
ascertain overall IQ when that is necessary for drawing diagnostic conclusions.
In addition to accounting for a child’s IQ, evaluations should include assessment of those
neurocognitive domains associated with ADHD, including attention, working memory, executive
functioning, and processing speed (Mahone & Schneider, 2012). Attention is a complex
neurocognitive construct. In assessment, it is typically measured via selective and sustained
attention tasks, such as continuous performance tasks that measure attentional performance over
time. Scores on continuous performance tasks usually include omissions and commissions,
which reportedly indicate inattention and impulsivity, respectively. However, other subtests
included in the core subtest of the cognitive batteries also provide some indication of attentional
problems. Attentional capacity can be determined by any test with a fleeting stimulus (either
visual or auditory) that is presented once before the examinee is asked recall it.
Working memory is the ability to hold and manipulate information in the mind (Cowan &
Alloway, 2009). Many working memory tests have been designed to assess components of
Baddeley’s multi-component model including the visuo-spatial sketch pad, the central executive
system, the phonological loop, and the episodic buffer (A. Baddeley, 2000, 2003; Baddeley et
al., 2011). Common measures of working memory require the individual to hold onto verbally
presented information and reorder it (e.g., WISC Digit Span Backwards and Sequencing). When
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asked to reorder backwards, the task requires spatial revisualization. When asked to sequence the
stimulus by a familiar organizational framework (e.g., first in alphabetical and then numerical
order), auditory acoustic memory is required.
Executive functioning broadly refers to higher order cognitive processes involved in
formulating goals, planning, organization, and performance maintenance (Lezak et al., 2012).
There are lower-level executive functions (e.g., sequencing and shifting/cognitive flexibility,
inhibition, inhibition with switching) and higher-level executive functions (e.g., complex
problem solving, ability to shift problem solving strategies based on real-time feedback). Lower
level executive functions develop earlier, while higher-level executive functions continue to
develop through adolescence (Best & Miller, 2010). Therefore, children with ADHD exhibit
lower-level executive dysfunction.
Speed of information processing refers to the ability to process and respond to stimulus
accurately. Measures of processing speed are different from tests of simple reaction time or
visual discrimination because they require some component of cognitive decision making and
allow for learning over time. Low speed of information processing may be indicative visual
discrimination problems, distractibility, slowed decision making, motor difficulties, and/or
generally slow cognitive speed (Wechsler, 2014).
Risk Factors. There are numerous etiological risk factors for ADHD, in addition to
stress, especially among higher risk populations (e.g., racial/ethnic minority children, low
socioeconomic status, religious minorities, sexual minorities). Genetic heritability is the
strongest predictor of ADHD (Biederman, 2005; Du Rietz et al., 2018; Faraone et al., 2005;
Franke et al., 2012; Leung & Hon, 2016). Following this risk factor, within the prenatal
environment, intrauterine exposure to substances such as alcohol is a significant risk factor for

NEUROCOGNITION IN CHILDREN BORN LAMP

11

ADHD. Additionally, there is substantial substance use in the USA during pregnancy (Franke et
al., 2018; Knopik et al., 2018; Spiers et al., 2015). Tobacco, alcohol, cannabis, and other illicit
substances are the most common substances (Forray & Foster, 2015; Knopik et al., 2018).
Tobacco use during pregnancy and prenatal alcohol exposure (PAE), which may lead to Fetal
Alcohol Syndrome (FASD), are strong predictors of psychiatric and emotional problems, school
disruptions, legal difficulties, and behavioral problems (Williams & Smith, 2015). In-utero
exposure to substances substantially increases the risk for negative neurocognitive outcomes and
behavioral problems including ADHD (Tsang et al., 2016).
Furthermore, it is crucial to consider postnatal factors such as environmental exposures.
Lower socioeconomic status (SES) poses a risk for negative outcomes and may be associated
with increased likelihood of exposure to teratogens (e.g., lead), infections (e.g., encephalitis),
abuse/neglect, an unstable home environment, maternal smoking, nutritional factors, and parental
psychopathology (American Psychiatric Association, 2013; Braun et al., 2006; Humphreys et al.,
2018; Russell et al., 2014).
One of the strongest perinatal risk factors for ADHD is preterm birth. Those who are born
prematurely show a two- to three-fold risk of developing ADHD (American Psychiatric
Association, 2013). Research has demonstrated a dose-response relationship between early
gestation and psychiatric morbidity, specifically ADHD (D’Onofrio et al., 2013). This
relationship was independent of familial confounds (e.g., age at first parenthood, marital status,
social welfare recipient) and child (e.g., sex, birth order, year of birth) and parent (e.g., age at
index child’s birth, education level, history of criminal conviction) covariates consistent with
causal inference (D’Onofrio et al., 2013). Prematurity is a unique risk factor for ADHD even
after accounting for other risk factors.
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Symptom-Mitigating Factors. Children with ADHD present with a sequela of
symptoms. In addition to behavioral symptoms (inattention, hyperactivity, impulsivity) and
neurocognitive deficits in attention (including attention, working memory, executive functioning,
and processing speed), children with ADHD are more likely to present with social skills deficits
and adaptive behavior deficits (Deboo & Prins, 2007; Lindblad et al., 2013; Staikova et al.,
2013). Social skills and adaptive behaviors can be learned naturalistically, as well as through
evidence-based interventions. Therefore, it is worth considering that bolstering these skills areas
may help to reduce the overall ADHD-related symptom burden and may be conceptualized as
symptom-mitigating factors. It may be the case that those children who have ADHD-related
neurocognitive deficits remain subthreshold for a diagnosis because they are able to utilize peer
relationships and adaptive behavioral strategies to minimize functional impairment caused by
their ADHD.
Diversity Issues. There are numerous diversity issues related to ADHD. Firstly, the
literature shows that stress negatively impacts cognition (Mueller et al., 2010). Secondly, greater
life stress is associated with a higher ADHD symptom report, which suggests that stress
exacerbates ADHD symptomatology (Sasser et al., 2016). Given that minorities experience a
greater amount of stress (S. Cohen & Janicki-Deverts, 2012), it logically follows that minorities
are at an increased risk for decrements to their cognitive performance and attentional
interference. Research has shown that African American children receive higher teacher ratings
of attention problems and are also less likely to receive treatment (DuPaul et al., 2016; Willcutt,
2010). It may be the case that minority children with ADHD experience symptom exacerbation
as a function of increased life stress, leading to higher ratings of attention problems. It is also
possible that minority children are more likely to be pathologized. This is a very significant
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problem when using informant reports of behavior as the foundation of evidence for a diagnosis,
such as in the case of ADHD.
Psychopathology of Late and Moderate Preterm (LAMP) Birth
Late and moderate preterm birth are high base rate occurrences, and preterm status is a
known risk factor for ADHD. Preterm birth is a significant problem, with LAMP occurring in
nearly 10% of babies born in the US (7.99% and 1.48% late and moderate preterm, respectively);
these rates are lower among singletons (6.99% and 1.18% late and moderate preterm,
respectively; Martin et al., 2015). Approximately 71% of all preterm births (GA < 37 weeks) fall
in the late preterm category (Martin et al., 2015), and greater than 80% of all preterm births are
LAMP (GA 32 to 36 weeks; Howson et al., 2012). LAMP infants represent a significant
population among the general population and the vast majority within the preterm population.
There has been a more recent wave of literature devoted to LAMP infants, who represent most of
all preterm births. The proposed study seeks to better understand the risk and symptommitigating factors that determine the pathogenesis from LAMP birth to ADHD; extremely
preterm and very preterm infants (those born before 32 weeks’ gestation) will be excluded owing
to the high prevalence of medical comorbidity and complexity in these groups.
Definitions. Preterm birth refers to babies born before 37 weeks of gestation; it can be
further subdivided into extremely preterm (at/before 25 weeks), very preterm (less than 32
weeks), moderately preterm (32 to 33 weeks), and late preterm (34 to 36 weeks; Mayo
Foundation for Medical Education and Research, 2017). Late and moderate preterm are often
grouped together and may collectively be referred to as LAMP infants (Howson et al., 2012;
Menon, 2008). Full-term babies are also subdivided into early term (37 to 38 weeks), full term
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(39 to 40 weeks), late term (41 weeks), and post term (at or after 42 weeks; March of Dimes,
2018).
Gestational age (GA) and birth weight are closely related, and birth weight is sometimes
used as a proxy for GA (Taylor, 2010). Essentially, low birth weight (LBW) suggests
prematurity. LBW is less than 2500g (World Health Organization, 2014). Much like preterm
birth can be categorized into subgroups, so too can low birth weight: very low birth weight
(VLBW) is less than 1,500 grams and extremely low birth weight (ELBW) is less than 1,000
grams. However, LBW can be indicative of preterm birth, intrauterine growth restriction/fetal
growth restriction, or both (Cutland et al., 2017). LBW may represent a construct other than GA,
and consequently, this study is most interest in LAMP status determined by GA rather than as
indicated by birth weight. Nevertheless, this study examined the interactive effect of LBW on
GA in determining ADHD status.
Outcomes Following LAMP Birth. Though LAMP infant survival rates have improved
over the last decade with medical advances, late preterm death still accounts for 10-15% of
global neonatal deaths (Osrin, 2010). The incidence of early and late neonatal death is 2.8 per
1000 among LAMP compared to 0.4 per 1000 in term-born controls (Bonnevier et al., 2018).
LAMP infants are at higher risk for respiratory distress, transient tachypnea, intraventricular
hemorrhage, bacterial sepsis, feeding problems, neonatal intensive care unit (NICU) admission,
and death (Shapiro-Mendoza & Lackritz, 2012). Hypoglycemia, jaundice, temperature
instability, apnea, and the need for intravenous infusion are also common (Engle et al., 2007).
The brain develops in a caudal-to-rostral direction, and therefore, frontal (especially prefrontal
cortex) regions and networks connected to these regions, which are last to develop, are
negatively impacted by a shortened gestational period (Kolb et al., 2012). LAMP infants that
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survive infancy go on to show differences in their neurodevelopment compared to full term
infants. These children show higher rates of neuromotor/sensory impairment, including hearing,
vision, and gross motor impairments. They also have higher rates of neurodevelopmental
disability status (Johnson et al., 2015). By school age, there are differences in LAMP children’s
academic achievement. They show slower language acquisition and social-emotional
development (Johnson et al., 2018) compared to their same-aged peers.
During the course of development, neuropsychological differences become evident, and
these deficits become measurable. The development of attention networks is disrupted in preterm
birth (Ball et al., 2014; Rommel et al., 2017; van den Heuvel et al., 2015). These children show a
higher prevalence of cognitive impairments, including nonverbal and expressive language
deficits (Johnson et al., 2015). They exhibit statistically significant differences on performancebased measures (administered at age 7-years) of intellectual functioning, visuospatial reasoning,
attention control, and inhibition (Cserjesi et al., 2012; Kerstjens, 2013). In addition to differences
in neuropsychological status, there are also differences in behavioral functioning. The parents of
LAMP children report increased problems with executive functioning and behavioral regulation
compared to parents of term-born children (Cserjesi et al., 2012; Kerstjens, 2013). Taken
together, there are consistent brain-behavior deficits associated with LAMP status that would
predispose children to ADHD symptomatology (e.g., problems with attention and inhibition).
Risk Factors. There are numerous risk factors for LAMP, many of which have an impact
on outcome after birth. Prenatal risk factors for spontaneous preterm birth include maternal age,
pregnancy spacing (e.g., short interval and long interval between births), multiple pregnancy,
infection (e.g., STIs, HIV/AIDS, Rubella), underlying maternal chronic health condition (e.g.,
diabetes, hypertension, anemia), nutrition (e.g., folic acid and iron deficiencies), stress (e.g.,
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working more than 5-days/week, heavy lifting), maternal psychological health (especially
depression), trauma exposure (e.g., intimate partner violence), substance use (e.g., tobacco,
alcohol, illicit substances), and genetic heritability (Howson et al., 2012; Shapiro-Mendoza &
Lackritz, 2012). The most common causes of late preterm births are preterm premature rupture
of the membranes (PPROM), hypertensive diseases, pre-gestational diabetes, and placental
disorders (Bonnevier et al., 2018). Notably, many of the prenatal risk factors for LAMP birth
reflect the health disparities prevalent among low socioeconomic status (SES) and ethnic/racial
minorities in the US.
While two-thirds of preterm births are spontaneous, one-third are medically indicated
(Shapiro-Mendoza & Lackritz, 2012). Perinatal risk factors observed in provider-initiated
preterm birth include obstetric indication (labor arrest, multiple gestation, fetal malposition),
fetal indication (fetal heart rate, suspected fetal macrosomia), or another not medically indicated
reason, such as elective caesarian (Barber et al., 2011; Howson et al., 2012). The latter—elective
cesarean—is becoming an increasingly common practice (Davis-Floyd, 2007). The culture in the
US is particularly problematic, as the rate of physician-initiated elective caesarians are higher
than other developed nations, often resulting in LAMP birth (Morris, 2016; Rosenberg &
Trevathan, 2018).
Once a child is born LAMP, there are certain prognostic factors that would predict
severity of consequent development. Predictors of a very preterm phenotype (characterized by
early delays and school-aged deficits in cognitive processing, attention, social/emotional
functioning, and autism spectrum disorder-like symptoms) in LAMP children include
preeclampsia during pregnancy and being male (Johnson et al., 2018). Other studies show that by
age 7-years, preterm boys have regressed to the mean, catching up to their full term birth peers,
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whereas preterm girls lag behind their peers (Cserjesi et al., 2012; Kerstjens, 2013). Therefore,
the role of gender remains unclear, though existing research suggests that its role is dynamic and
changes over the course of development. SES is another prognostic factor, contributing to an
increased likelihood of developmental delay above and beyond the risk accounted for by
moderate preterm birth itself (Potijk et al., 2013).
Diversity Issues. There are numerous diversity issues in both the occurrence of LAMP
birth and its long-term outcomes. As previously mentioned, many of the prenatal risk factors for
LAMP birth are disproportionately present among low income and racial/ethnic minorities.
Consequently, a significant racial disparity exists in the rates of preterm birth; African
Americans have two- to three-fold risk compared to Caucasians (Menon, 2008). This disparity is
not fully attributable to factors such as SES, maternal behavior (e.g., in-utero exposure to
tobacco, alcohol, drugs), age, gravidity, marital status, education, or income (Menon, 2008).
Rather, the etiology of LAMP birth is likely multifactorial, with contributions from biological
(e.g., genetic, nutrition) and psychosocial factors (e.g., environmental risk factors, SES), that
interact in a complex system. SES, as previously mentioned, is both a risk for LAMP and
impacts the prognosis of LAMP born children. This is yet another reflection of the ways in
which decades of institutional racism have resulted in health disparity and differential access and
quality of care and intervention services.
Notably, gestational age cutoffs used to define prematurity are arbitrary. There is
substantial evidence to suggest that the 37-week cutoff should be raised; children born close to
term, as it is currently defined, show poorer outcomes than do children born closer to 40 weeks’
gestation (Goldenberg et al., 2012). There is significant evidence to suggest that studying the
long-term outcomes of LAMP infants is crucial, as this group accounts for the highest percentage
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of preterm births and their long-term outcomes shed light on the role of late gestation on
development. Furthermore, full-term subjects should be assigned more discrete group
membership. Since the variables of interest in the present study revolve around the last weeks of
gestation, the late and moderate preterm born children will be examined as the two experimental
groups, and early and full term born children will be examined as the control groups.
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Chapter 2: LAMP and ADHD Research
Though recent research has focused on LAMP infants, findings have been mixed
regarding the relationship between LAMP status and longer-term outcomes such as ADHD and
associated delays and deficits. A closer examination of the literature highlights some of the
strengths in the existing studies, and the limitations of others, which make it difficult to
conclusively remark on the attention capacity of LAMP born infants by school-age.
Research Concluding No Difference in ADHD Outcomes Among LAMP Children
Rabie et al. (2015) conducted a retrospective study to examine the neurodevelopmental
outcomes (specifically ADHD and/or developmental speech and language disorders, as defined
by the ICD-9CM) among late preterm children as compared to early term and term born controls
via a review of the Medicaid record among 3,270 late preterm infants and 24,005 term infants.
Gurka et al. (2010) conducted a prospective study to compare late preterm infants and full-term
controls from the age of 4 years to 15 years on measures of cognition, achievement, socioemotional, and behavioral outcomes among 1,298 children (53 of which were born late preterm).
Both studies concluded that there were no differences between LAMP children and term born
controls on outcomes related to ADHD. There are several explanations for these findings
outlined below, with suggestions for how the problems will be addressed in the present study.
Study Designs. Gurka et al. (2010) observed children from birth through the age of 15
years. Data collection took place at age 54 months, and continued yearly from kindergarten
through the sixth grade, with follow-up at the age of 15 years. The strength of longitudinal work
such as this is that data is collected across development and can capture the changes associated
with development as well as intervention. However, given that it is more difficult to recruit
participants who are willing to participate long-term, the Gurka et al. (2010) study only included
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53 late preterm participants. Gurka et al. (2010) did not perform power analyses; rather, they
chose to provide a range of possible differences between groups based on confidence intervals to
conclude whether the suggestion of equivalence between groups was appropriate. While
provision of confidence intervals was a valuable redress, overall, the study was underpowered
(preterm group N = 53). The present study was much better powered and able to detect medium
effect sizes.
Rabie et al. (2015) utilized archival data with variables that were not designed for
psychological research. Specifically, they determined ADHD by ICD-9 code as an outcome
based on review of the Medicaid record. However, diagnostic codes by insurance record are
subject to error and bias and may not represent the child’s full medical record. That the variables
utilized in the study were not designed for research, nor were they comprehensive clinical
indicators, is a weakness of this retrospective research design. The present study improves upon
this point by utilizing diagnoses formulated following a comprehensive neuropsychological
evaluation (rather than diagnostic codes used in billing) and performance-based measures of
neurocognition.
Subjects for both studies were sorted into clinical and control groups based on gestational
age, but classification of preterm status varied by study. Measurement of and classification based
on gestational age can be accomplished several ways, and each way has its own strengths and
weaknesses. Rabie et al. (2015) used GA indicated on birth certificates. This methodology is
highly accurate, though difficult in retrospective studies of older children who are more likely to
receive care in hospitals other than the one they were born in. Gurka et al. (2010) determined GA
using birthdate and due date, as reported by parents; this is potentially problematic owing to
parental error in report. However, this is a common method, requiring less effort in data
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collection. The present study will utilize gestational age based on parent report, but it will also
review the electronic medical record (EMR) for the hospital-recorded GA of those children who
were born within an identified hospital system in a large metropolitan area as a secondary means
for examining accuracy of parent-reported GA.
Many studies look at full-term children without regard for their gestational age. Rather
than subsuming “full-term” into one heterogenous group, it is important to look at smaller,
incremental groupings. Rabie et al. (2015) addressed this issue and provided two term groups:
early term (37 to 38 weeks’ gestation) and term born (39 to 41 weeks’ gestation), which allowed
for multiple control group comparisons to the late preterm group. However, the study failed to
include children born moderate preterm. As noted previously, each week of gestation plays an
important role in neural development. Consequently, inclusion of discrete groups is an important
step in better understanding the long-term outcomes of shortened gestation. The present study
will include Moderately preterm (32 to < 34 weeks), Late preterm (34 to < 37 weeks), Early term
(37 to < 39 weeks), and Full term (39 to 40 weeks), with the preterm children collectively
referred to as LAMP children, and the full-term children collectively referred to as term-born
children.
Lastly, the time of diagnostic review changes prevalence rates of ADHD among LAMP
children. Rabie et al. (2015) chose to include subjects between the ages of 3 and 5 years. This is
extremely problematic as most children in their sample who would later be diagnosed with
ADHD were not captured in their analyses. Diagnoses for ADHD are most often made after
formal schooling has begun, when the child has had time to build instructional control and adjust
to the behavioral routine of full-time schooling, and informants (e.g., parents, teachers) are able
to compare the child’s behavior to other similarly-aged children (Evans et al., 2010). The present

NEUROCOGNITION IN CHILDREN BORN LAMP

22

study improves upon this by examining children in middle childhood who are more likely to
have exhibited ADHD-related deficits relative to their peers.
Inclusion/Exclusion Criteria. Rabie et al. (2015) excluded subjects if they were part of
multiple births, were small or large for gestational age, and/or had a congenital anomaly. This is
problematic as a high proportion of LAMP infants are from multiple births. “Congenital
anomaly” is not specifically defined and may have included cosmetic congenital anomalies that
would not otherwise impact neurocognitive development or have subsequent impact on
neuropsychological status/ADHD as an outcome. Rabie et al. (2015) also failed to exclude
participants on the basis of IQ. The amount of variance in neurocognitive presentation accounted
for by an extreme departure from the mean IQ of 100, as is the case in intellectual disability
(generally indicated by an IQ below a standard score of 70), can significantly skew the results.
The present study allowed for multiple birth children and excluded those children with
intellectual disability (as diagnosed following comprehensive neuropsychological evaluation).
Gurka et al. (2010) also utilized a somewhat biased sample; the exclusion criteria stated
that the family had to live within one hour of the research site, which limited participants to those
who lived within metro city limits. Furthermore, it was stipulated that participants had to live in
neighborhoods that were sufficiently safe for researchers to visit, though how this was
determined is unclear and clearly limits higher risk participant inclusion. Additionally, the
families were told not to participate if they planned to move anytime in the next three years.
There were additional exclusion criteria, including maternal and infant health factors, largely
related to SES and racial health disparity, maternal substance use, significant maternal or infant
illness, and greater than seven-day hospital stay at birth. Taken together, the exclusion criteria
limited the sample population so that those who were recruited had a higher SES and had higher
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educational levels. The sample lacked diversity in racial backgrounds and did not include a rural
representation. Therefore, the conclusions drawn from this study have extremely limited external
validity. Gurka et al. found that the children born late-preterm showed no differences to the
children born full-term in all examined child and family characteristics. This is likely an artifact
of the biased sample rather than a reflection of the general population in the USA, in which many
of the exclusion criteria are factors disproportionately represented among babies born LAMP and
children with ADHD.
Rabie et al. (2015) utilized all Medicaid subjects in the review, but a Medicaid-based
population is more likely to have poorer obstetric outcomes, lower SES, and significant drop off
in Medicaid enrollment compared to mixed insurance samples (i.e., a sample that would have
included private insurance). These types of confounds and biases in the data need to be
statistically redressed. Specifically, poorer obstetric outcomes are their own risk factor in the
development of ADHD. Lower SES may restrict access to intervention services and enrichment
opportunities that could serve as factors that mitigate symptom severity or functional impairment
associated with ADHD. Drop-out in Medicaid enrollment leads to attrition bias and limits
statistical power. The present study includes both singletons and non-singletons from a highly
diverse population.
Variables. Regarding measurement error in criterion variables, Gurka et al. (2010)
measured cognition and achievement using subtests from the Woodcock-Johnson PsychoEducational battery (Rev. ed.; Picture Vocabulary, Passage comprehension, Letter-Word
Identification, and Applied Problems); however, the vast majority of these are related to
academic achievement rather than cognition. Although Picture Vocabulary, which measures
expressive fund of word knowledge, provides, at best, an estimate of overall IQ, it cannot
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provide an indication of strengths and weaknesses in the cognitive profile. Thus, Gurka et al.
(2010) fails to provide information regarding the cognitive domains of interest—those related to
ADHD and those which would be measurable in a sample of school-aged children. The present
study utilized testing instruments that were better attuned to neurocognitive functioning,
specifically those that captured weaknesses associated with ADHD.
Regarding behavioral symptoms, Gurka et al. (2010) used the Child Behavior Checklist
(CBCL) scales to generate standardized externalizing, internalizing, aggression,
anxiety/depression scores based on parent report (Achenbach & Rescorla, 2001). However, they
did not utilize other informants who primarily observed symptoms and functioning in settings
outside the home (i.e., teacher-report of symptoms in the school setting), nor did they utilize any
attention-specific measures (i.e., those that would be more sensitive to ADHD symptomatology).
The present study utilized several behavioral reports, including one which specifically targeted
attention-related impairment.
Rabie et al. (2015) controlled for alcohol abuse and preeclampsia as indicated in the
child’s Medicaid claims file, without regard for other risk factors predictive of both LAMP and
ADHD and without capturing factors the parents might have otherwise reported but were not
documented in the Medicaid medical record. The present study will report on multiple prenatal
and perinatal risk factors queried for in the evaluation (e.g., in-utero exposure to alcohol,
tobacco, illicit substances, prescription drugs, gestational diabetes, high blood pressure/toxemia,
infections, placenta abruptia, placenta previa, pre-eclampsia, maternal chronic illness, and major
life stress).
Additionally, several factors impact the perceived relationship between the predictor and
criterion variables. Many studies encounter the third variable problem—failure to consider
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moderators and/or mediators—and this may influence observed variables and cause them to
covary when in fact there is no direct relationship (Bordens & Abbott, 2018). Neither Rabie et al.
(2015) nor Gurka et al. (2010) included any moderators or mediators. The present study looked
at early intervention services and symptom-mitigating factors (e.g., social skills and adaptive
skills) as potential moderators between LAMP and ADHD/ADHD-related outcomes.
Research Finding Differences in ADHD Outcomes Among LAMP Children
Johnson et al. (2015) conducted a prospective study to examine neurodevelopmental
outcomes (specifically neurosensory and cognitive impairment) among LAMP children as
compared to term born controls via parent report among 638 LAMP children and 765 term
infants. Similarly, Sucksdorff et al. (2015) conducted a prospective study to examine GA as a
predictor for ICD ADHD diagnosis as indicated in the Finnish Medical Birth Register among
10,321 children with ADHD and 38,355 controls. Further, Rommel et al. (2017) and James et al.
(2018) conducted studies to examine ADHD symptoms and related cognitive impairments
between preterm-born children (N = 186), term-born children with ADHD (N = 69), and term
controls without ADHD (N = 135) via electroneurodiagnostics (specifically event related
potentials, or ERPs), skin conductance levels, and cued performance tasks. These studies all
concluded that there were statistically significant differences between LAMP children and term
born controls in early neurodevelopmental delays, higher rates and greater severity of ADHD,
ADHD associated neurocognitive deficits, and greater functional impairment (James et al., 2018;
Johnson et al., 2015; Rommel et al., 2017; Sucksdorff et al., 2015). These study designs, subject
selection, and measurement techniques provided a roadmap for the design of the current study.
Study Design. The age of study participants impacted outcome data for many of the
studies reviewed previously. Rommel et al. (2017) reviewed the differences in prevalence of

NEUROCOGNITION IN CHILDREN BORN LAMP

26

ADHD, ADHD-like symptoms, and related neurocognitive deficits among three different groups
of adolescents: those born preterm, those born full-term but diagnosed with ADHD, and those
born full-term without ADHD (who served as controls). The time of diagnostic review utilized in
the Rommel et al. (2017) study is likely accurate, as measurement in adolescence is more likely
to capture ADHD prevalence than when prevalence is measured in early childhood. ADHD
diagnoses likely have been made by adolescence and the associated neurocognitive deficits can
reliably be measured. Notably, the prefrontal cortex continues to develop into early adulthood,
and thus it is possible that the neurocognitive presentation and/or deficits associated with ADHD,
including functional and adaptive deficits, may further change and present differently later in
development. This is one of the reasons that the present study examined outcomes in middle
childhood when neurocognitive functioning can be reliably measured, and prevalence estimates
are stable.
Sucksdorff et al. (2015) captured ADHD diagnosis over time, tracking subjects through
childhood, and required that diagnoses be given based on the International Classification of
Diseases (ICD-10; World Health Organization, 1992). Notably, the ICD-10 is a commonly used
diagnostic manual favored by European countries, and classifies ADHD as “hyperkinetic
disorder,” including symptoms of over activity, poor modulation of behavior, inattention, lack of
persistent task involvement that persists across settings and over time and is evident in early
childhood (World Health Organization, 1992). Sucksdorff et al.’s (2015) findings would be
stronger if they were replicated using DSM-5 criteria to increase reliability and external validity
in the US, which generally favors the DSM-5. Notably, differences in prevalence estimates
worldwide suggests that the methodological criterion used to determine diagnosis accounts for
significant variance (Levy, 2014). More specifically, though the ICD and DSM provide similar
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lists of symptoms, the ICD has been associated with lower prevalence rates as symptoms must
reach a certain threshold of severity in all dimensions whereas the DSM-5 requires that
symptoms be present across two of more settings (American Psychiatric Association, 2013;
Levy, 2014). The DSM-5 criteria for ADHD was used in this research study in order to maximize
generalizability of findings within a US population.
Control groups varied for many of the studies examining GA and ADHD. Sucksdorff et
al. (2015) matched children with ADHD to four controls groups based on birthdate (+ 30 days),
gender, and child birthplace. Controls were excluded if they had a diagnosis of ADHD, conduct
disorder, or severe or profound intellectual disability. By matching children with ADHD to
controls on these criteria, those characteristics can be eliminated as potential confounds that
could mistakenly lead to group differences in the variables of interest. Rather than utilizing a
matched-groups design, other studies have recruited control groups solely based on “full-term”
status, defined by a GA above 37 weeks. However, this can be problematic as there is data
showing that early term infants, those born 37 to 39 weeks’ GA, are also at higher risk for
developing neurological problems compared to those born at 40 weeks’ GA (Johnson et al.,
2015). The present study examined discrete groups of preterm and full-term children and utilized
control variables, rather than a matched-groups design.
Johnson et al. (2015) and Sucksdorff et al. (2018) were well powered studies (LAMP N =
1,130 and ADHD N = 10,321, respectively). Rommel et al. (2017) and James et al. (2018) were
smaller studies that were also able to detect differences in ADHD-related outcomes among
LAMP children. The present study is sufficiently powered and could detect large effect sizes.
Rommel et al. (2017) and James et al. (2018) required medical record verification of GA.
Sucksdorff et al. (2015) determined gestational age from last menstrual period and verified the
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GA using first trimester ultrasound results. Though the present study relied on parent-reported
GA, the medical record was also reviewed as a means of secondary assessment. Gestational age
is often used as a continuous variable, with groupings based on recommended classification
(Sucksdorff et al., 2015). However, using GA as a continuous variable among preterm children
can be problematic. Rommel et al. ’s (2017) standard deviation for GA among preterm children
was approximately 3 weeks—a significant period for gestational age; tighter grouping/more
stringent GA criteria would have been more useful. Groupings can be made using other
strategies. For example, Johnson et al. (2015) created a LAMP group (32 to < 37 weeks’
gestation), without dividing moderate from late preterm infants. The present study examined
discrete groups of preterm and full-term children, as well as compare the overall sample of
LAMP to term-born children.
Studies conducted by Rommel et al. (2017) and James et al. (2018) used a primarily
White population from England, which is very different from racial composition in the US. A
predominantly White sample very much limits the generalizability of findings and is particularly
problematic for drawing conclusions regarding US preterm children, many of whom are racially
diverse. The present sample successfully gathered data from racially/ethnically diverse patient
population by utilizing data from a healthcare system in a major Metropolitan area in the US.
Inclusion/Exclusion Criteria. Johnson et al. (2015) excluded subjects with major
congenital anomalies, though it was unclear whether these anomalies were those that impact
cognitive development. Rommel et al. (2017) excluded subjects with an IQ below a standard
score of 70, and those with general learning difficulties, cerebral palsy, epilepsy, medical
conditions affecting motor coordination, and brain disorders and genetic or medical disorders
that might mimic ADHD. This exclusion criteria (learning difficulties, specifically) limits
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variance in neurocognitive outcomes and is problematic as many children with ADHD have
comorbid specific learning disorders (Efron et al., 2016). The present study includes exclusion
criteria that functions to eliminate biases (e.g., ID) and other conditions that could account for
the relationship of interest (e.g., brain disorders and/or medical conditions that mimic ADHD or
directly impact attentional capacity), without diminishing expected variance in outcome due to
learning disabilities.
Variables. Maternal age, maternal substance abuse, maternal psychiatric history, in-utero
exposure to tobacco, gravidity, marital status, paternal age, and urbanity of the child’s birthplace
have all been shown to have an association with preterm birth (GA) and ADHD (Sucksdorff et
al., 2015). Sucksdorff et al. (2015) chose to examine confounders in relationship to preterm birth,
weight for gestational age, and ADHD, while controlling for factors related to the primary
predictor, secondary predictor, and criterion variable. Maternal SES and paternal psychiatric
history and immigrant status were additional confounds in predicting ADHD. After adjusting for
all confounds, premature birth remained a risk factor for ADHD. Rommel et al. (2017) did not
control for risk factors of preterm birth (e.g., malnutrition, low SES), which may covary with
associated neurocognitive deficits, or serve as moderators or mediators, especially by
adolescence (i.e., cumulative risk over time).
As noted above, there can also be measurement error in the criterion variables. Rommel
et al. (2017) used the Diagnostic Interview for ADHD in Adults (DIVA) to determine ADHD
status. Notably, this measure was normed for adults, though the study administered it to
adolescents, meaning that the tool may not have been appropriately sensitive to the symptoms
that present in adolescence. Johnson et al. (2015) utilized measures specific to cognitive ability
and, given that the outcome of interest was neurodevelopmental disability in early childhood,
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measures of more distinct cognitive domains were not required. The present study utilized tools
created for measuring neurocognition (including specific domains of interest) and behavior in the
target age-range.
Summary of Prior Research
ADHD and LAMP birth are both commonly occurring conditions. LAMP is a risk factor
for ADHD, but there are numerous biopsychosocial factors that contribute to this outcome. There
are identifiable biological disruptions in prematurity that relate to the observed disruptions in
attentional capacity associated with ADHD. There are also psychosocial factors that relate these
two conditions, including shared risk and prognostic factors. Yet there are many children born
LAMP who do not go on to develop ADHD. The multiplicity of outcomes among LAMP
children is captured in the existing body of literature. Though recent research has focused on
LAMP infants, findings have been mixed regarding the relationship between LAMP status and
longer-term outcomes such as ADHD and associated delays and deficits. Per review of the recent
relevant literature regarding outcomes following LAMP birth, including ADHD and ADHDrelated impairment, there is stronger evidence to support higher prevalence, greater symptom
severity, and higher functional impairment among those children born LAMP than term-born
controls (James et al., 2018; Johnson et al., 2015; Rommel et al., 2017; Sucksdorff et al., 2015).
The research that contradicts this conclusion has significant limitations, most notably
procedural timing, elements of bias (e.g., subject population), and poorly selected assessment
tools, that threaten validity and interpretive value (Gurka et al., 2010; Rabie et al., 2015). Prior
studies have largely examined gestalt measures of ADHD (diagnosis by history or by research
determination) or cognitive functioning (IQ). However, this does little to provide information
regarding the underlying neurocognitive deficits associated with both LAMP birth and ADHD.
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These components are crucial in the understanding of decrements to overall functioning that
contribute to the functional impairment that warrants a diagnosis.
Taken together, it is crucial to understand what factors predict resilience in this high risk,
high base-rate group of LAMP children, in the hope that behavioral and biological plasticity will
prevail, and that these children will adapt and not develop impairments that warrant an ADHD
diagnosis. Identifying and understanding the biopsychosocial relationship between
ADHD/ADHD-related neurocognitive outcomes and LAMP birth is a crucial first step. The
purpose of the present study was to examine (a) ADHD and associated neurocognitive deficits
among full-term and LAMP born children, (b) which factors predict improved neurocognition
among high-risk LAMP born children, and (c) which factors are the strongest predictor(s) of an
ADHD diagnosis among LAMP children. By gaining a better understanding of the risk and
symptom-mitigating factors that may alter the diagnostic status (functional impairment) and
symptom severity among LAMP children at school-age, early intervention services can be better
tailored to this population who are at risk for attentional deficits.
Hypotheses
The study contributes to the existing literature on LAMP and ADHD in several ways.
Firstly, it provided updated statistics in prevalence rates among more discrete groups of preterm
(LAMP) and full-term born children. Secondly, it examined ADHD as the heterogeneous
outcome that it is—a diagnostic label, behavioral presentation (i.e., symptom severity), and
distinct neurocognitive deficits. Thirdly, it utilized patient history as well as behavioral reports to
ascertain which risk and symptom-mitigating factors further illuminate the relationship between
GA and ADHD outcomes.
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The present study utilized a school-age population, when neurocognitive processes,
including the executive functions, can be measured reliably. De-identified patient data were
collected at a major hospital system in a large metropolitan area in the Midwest and included
children between the ages of 8 and 12 years. Efforts were made to include an equal number of
male and female children in the analyses, with a goal of 200 children total (100 LAMP children
with approximately 50 moderate preterm and 50 late preterm, and 100 term-born children with
approximately 50 early term and 50 full-term).
Overall neurocognitive functioning (g or IQ) was measured using the FSIQ of the WISCV. Discrete measures of neurocognitive functioning were taken across the following domains:
sustained attention, specifically brief attention, inattention and impulsivity; working memory,
specifically spatial revisualization and auditory acoustic memory; executive functioning,
specifically cognitive flexibility and inhibition; processing speed, specifically speeded
visuomotor integration and visual attention and matching. These measures capture those
neuropsychological deficits associated with ADHD (Mahone & Schneider, 2012). Diagnostic
status (i.e., ADHD or other diagnosis) were taken from the medical record. Behavioral reports
from parents were utilized as an indication of symptom severity (impulsivity, hyperactivity,
inattention). Risk factors (e.g., race, Medicaid status, parent educational level, genetic
heritability, and prenatal exposure to substances) were taken from the medical record.
Environmental factors that predict better outcomes were also examined. Firstly, history of early
intervention services was taken from the patient history form. Secondly, given that ADHD is also
related to social skills and adaptive behavior deficits (Deboo & Prins, 2007; Lindblad et al.,
2013; Staikova et al., 2013), these skill areas may function as symptom-mitigating factors that
reduce functional impairment and thus the likelihood of diagnosis, as well as symptom severity.
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Symptom-mitigating factors (e.g., social skills and adaptive skills) were captured in the
behavioral reports. Table 1. provides an overview of all predictor and outcome variables. The
following text describes the hypothesized relationships between these variables.
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Table 1
Summary of Variables Included in Primary Analyses
Predictors

Outcomes

Gestational age

ADHD diagnosis (as determined by neuropsychologist)

GA (weeks, by caregiver report)
LAMP (yes/no)
Risk factors (by caregiver report)

Symptom severity (by caregiver report on behavior rating forms)
Attention/Inattention (BASC-3; Conners-3)
Hyperactivity/Impulsivity (BASC-3; Conners-3)

Minority status (yes/no)

DSM ADHD Inattentive Symptoms (Conners-3)

Lack of caregiver higher level education (yes/no)

DSM ADHD Hyperactive/Impulsive Symptoms (Conners-3)

Medicaid status (yes/no)

Neurocognitive functioning (performance-based measures)

Genetic heritability (yes/no)

g/IQ (WISC-V FSIQ)

Prenatal exposure to substances (yes/no)

Attention (CPT2/CPT3; WISC-V DSF)

Symptom mitigating factors (by caregiver report)

Working memory (WISC-V DSB & DSS)
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Table 1 continued
Predictors

Outcomes
Executive functioning (D-KEFS TMT4/Children's Trails
B; D-KEFS CWIT3/NEPSY Inhibition; D-KEFS CWIT4/

Participation in early intervention services
Social Skills (BASC-3, ABAS-3)
Adaptive Skills (BASC-3, ABAS-3)

NEPSY Inhibition-Switching)
Processing speed (WISC-V PSI)
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Behavior Rating Scales
ADHD Diagnosis and Symptom Severity as Outcome—Hypothesis 1. The first
hypothesis examined the relationship between the child’s gestational age (GA) at birth and
diagnostic status from the patient data files, specifically prevalence of ADHD and symptom
severity. While the continuous GA and categorical GA variables are effectively the same, it was
expected that there would be group differences. Therefore, if GA as a continuous variable was
found to be significant, then additional analyses were conducted to look at GA group differences.
Both diagnostic status (yes/no ADHD) and the symptom severity of ADHD (parent report of
inattention, hyperactivity/ impulsivity, attentional problems, and/or total ADHD problems) were
examined in the analyses.
1a. A t-test was used to determine whether the average gestational age (GA) was
different between those children diagnosed with ADHD and those children who were not
diagnosed with ADHD. It was predicted that children with ADHD would have a significantly
lower mean GA than children without ADHD.
1b. A chi-square test was used to determine whether there would be a significant
difference between expected and observed rates of ADHD diagnosis (yes/no) by GA as a
categorical variable (late preterm, moderate preterm, early-term, and full-term). It was predicted
that LAMP children would exhibit greater than expected rates of ADHD, and term-born children
would not.
1c. Bivariate correlational analyses were conducted to examine if GA as a continuous
variable was related to symptom severity indicated via behavioral report. The specific symptoms
to be analyzed were inattention, hyperactivity/impulsivity, attention problems, and/or total
ADHD problems. It was predicted that GA would be negatively correlated with symptom
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severity: the closer a child is to 40 weeks’ gestation at the time of birth, the lower the ADHD
symptom severity.
1d. An analysis of covariance, ANCOVA, was used to determine if there were significant
differences in symptom severity between LAMP and full-term groups, after accounting for any
significant covariates (e.g., ADHD medication). It was predicted that the average symptom
severity would be highest among moderate preterm children, followed by late preterm children,
early term children, and lastly full-term children. The ANCOVA analysis would pinpoint the
precise GA that places children at risk of developing ADHD symptoms.
Risk Factors Impacting Diagnosis and Symptom Severity—Hypothesis 2. This
hypothesis examined the relationship between several risk factors (race, SES, parent educational
level, genetic heritability, prenatal exposure) and ADHD in the sample. Both the global diagnosis
of ADHD and the severity of ADHD symptoms as reported by the parents were examined in
relation to these risk factors.
2a. Chi-square tests were run to examine the difference between expected and observed
risk factors based on diagnostic status (yes/no ADHD). It was predicted that those with risk
factors would exhibit greater than expected rates of ADHD diagnosis (i.e., non-white racial
status, lower SES group, lower parental education, presence of the likelihood of genetic
heritability for ADHD, and presence of various prenatal environmental risk factors).
2b. T-tests were run to examine mean score differences in symptom severity by risk
factors (race, SES, parent educational level, genetic heritability, prenatal exposure). It was
predicted that caregivers would report higher mean symptoms of attention problems/inattention
and hyperactivity/impulsivity on behavior rating forms if they also endorsed the following risk
factors in their child’s history: racial minority status, parents without higher level education,
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Medicaid insurance rather than commercial, genetic heritability for ADHD, and/or history of inutero exposure to substances (alcohol, tobacco, illicit substances).
Symptom Mitigating Factors—Hypothesis 3. This hypothesis examined the
relationship between several factors hypothesized to mitigate ADHD symptoms. Because early
intervention services are likely to have a positive impact on development, it was hypothesized
that a history of early intervention services would be negatively related to ADHD-symptom
severity. Secondly, since ADHD is often associated with poor social skills and diminished
adaptive skills, it was hypothesized that children who have strength in these areas would exhibit
diminished symptom severity. Early history of intervention services, social skills, and adaptive
skills are collectively referred to as symptom-mitigating factors and represent the hypothesized
negative relationship between these factors and ADHD outcomes.
3a. Chi-square tests were run to examine the difference between expected and observed
symptom-mitigating factors (history of early intervention services, current social skills, and
adaptive skills) based on diagnostic status (yes/no ADHD). It was predicted that those without
symptom-mitigating factors would exhibit greater than expected rates of ADHD diagnosis, and
those with symptom mitigating factors would not.
3b. T-tests were run to examine the mean difference in symptom severity by symptommitigating factors. It was predicted that mean symptom severity would be lower among those
children with higher symptom-mitigating factors.
Additional Factors Impacting Relationship Between GA, ADHD Diagnosis, and
Symptom Severity—Hypothesis 4. We examined the additive predictive power of risk factors
and symptom mitigating factors with GA on ADHD symptom severity. This was done to clarify
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what amount of variance in ADHD-related symptoms could be accounted for by GA, other
known risk factors, and the hypothesized symptom mitigating factors.
4a. Of those risk factors found significantly correlated with ADHD symptom severity
from Hypothesis 2, a multiple linear regression was conducted to examine which of those risk
factors accounted for significant variance in predicting symptom severity, above and beyond
what was accounted for by gestational age. It was predicted that the risk factors would account
for additional variance in predicting ADHD-related symptom severity.
4b. Of those symptom-mitigating factors found significantly correlated with ADHD from
Hypothesis 3, a logistic regression was conducted to examine which of those risk factors
accounted for significant variance in predicting a diagnosis of ADHD, above and beyond what
was accounted for by gestational age. It was predicted that the symptom mitigating factors would
account for additional variance in predicting an ADHD diagnosis.
Neurocognitive Outcomes
The first four hypotheses were related to behavioral symptom presentation and diagnostic
status; the following hypotheses investigated the underlying neurocognitive dysfunction
theorized to underly that behavioral presentation.
Relationship Between GA and Neurocognitive Functioning—Hypothesis 5. This
hypothesis examined the relationship between GA and neurocognitive functioning in the
following domains: overall intelligence (g/IQ), attention (selective, sustained, brief), working
memory (spatial revisualization, auditory acoustic memory), executive functioning (cognitive
flexibility, inhibition, inhibition with switching), and processing speed. Firstly, correlational
analyses were conducted with the expectation that across domains, GA would be negatively
correlated with neurocognitive functioning. Independent samples t-tests were conducted to
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highlight the differences between LAMP children and term-born infants across neurocognitive
domains. ANOVA analyses were used to pinpoint if the specific GA categories were relevant in
determining severity of neurocognitive deficits.
5a. It was predicted that GA would be negatively related to g/IQ, attention, working
memory, executive functioning, and processing speed (bivariate correlational analyses).
5b. It was predicated that LAMP children would have lower average scores than termborn children on measures of g/IQ, attention, working memory, executive functioning, and
processing speed (independent samples t-tests).
5c. It was predicted that lower performance on measures of g/IQ, attention, working
memory, executive functioning, and processing speed would correspond to GA group
(moderately preterm, late prem, early term, and full-term, respectively).
Additional Factors Impacting Relationship Between GA and Neurocognitive
Functioning—Hypothesis 6. This hypothesis examined the relationship among identified risk
factors, symptom-mitigating factors, and the outcome variables of interest (neurocognitive ability
in the domains of attention, working memory, executive functioning, and speed of information
processing). Although researchers have examined the risk factors for ADHD (American
Psychiatric Association, 2013; Biederman, 2005; Braun et al., 2006; D’Onofrio et al., 2013; Du
Rietz et al., 2018; Faraone et al., 2005; Forray & Foster, 2015; Franke et al., 2012, 2018;
Humphreys et al., 2018; Knopik et al., 2018; Leung & Hon, 2016; Russell et al., 2014; Spiers et
al., 2015; Tsang et al., 2016; Williams & Smith, 2015), none have examined how these factors
map onto discrete neurocognitive skill deficits. It may be that examining these relationships in
LAMP children is particularly critical for understanding how environmental factors affect
children who are already at higher risk for developing ADHD. Once the significant risk factors
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and symptom mitigating factors were identified in the current sample, this hypothesis examined
which of those factors accounted for the greatest variance in predicting domain-specific
performance.
6a. Bivariate correlational analysis were conducted for all risk factors (race, SES, parent
educational level, genetic heritability, prenatal exposure) with all neurocognitive domains (brief
and sustained attention, spatial revisualization and auditory acoustic memory, cognitive
flexibility, inhibition, inhibition with switching, and processing speed). It was predicted that the
risk factors would be significantly correlated with each outcome (positively correlated in the case
of higher performance-based scores indicating deficits, and negatively correlated in the case of
higher performance-based scores indicating better performance).
6b. Bivariate correlational analysis were conducted for all symptom-mitigating factors
(history of early intervention services, social skills, and adaptive skills) and all neurocognitive
domains (brief and sustained attention, spatial revisualization and auditory acoustic memory,
cognitive flexibility, inhibition, inhibition with switching, and processing speed). It was
predicted that the symptom-mitigating factors would be significantly correlated with each
outcome (negatively correlated in the case of higher performance-based scores indicating
deficits, and positively correlated in the case of higher performance-based scores indicating
better performance).
6c. Of those risk factors found significantly correlated with neurocognitive outcomes,
hierarchical regression analyses were conducted to examine whether those risk factors account
for significant variance within neurocognitive domain, above and beyond what would be
accounted for by gestational age. It was predicted that the risk factors would account for
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additional variance in performance-based neurocognitive outcomes above what was accounted
for by gestational age.
6d. Of those symptom-mitigating factors found significantly correlated with
neurocognitive outcomes, hierarchical regression analyses were to be conducted to examine
whether those factors account for significant variance within the neurocognitive domains, above
and beyond what was accounted for by gestational age. It was predicted that the symptommitigating factors would account for additional variance in performance-based neurocognitive
outcomes above what was accounted for by gestational age.
Experimental Analyses
Interaction between GA and Additional Factors in Predicting Neurocognitive
Outcomes—Hypothesis 7. To better understand how environmental factors and history interact
with GA in predicting long-term neurocognitive abilities, moderation analyses were conducted.
Cumulative risk was derived from the number of endorsed risk factors.
7a. It was predicted that there would be a significant interaction between gestational age
and cumulative risk in predicting neurocognitive ability by domain.
7b. It was predicted that there would be a significant interaction between gestational age
and cumulative protection (i.e., total symptom mitigating factors) in predicting neurocognitive
ability by domain.
Interaction between GA and Birthweight in Predicting Neurocognitive Outcomes—
Hypothesis 8. Though the focus of the present analyses were on gestational age rather than
birthweight, experimental analyses were conducted to examine the interaction birthweight has
with gestational age in predicting long-term neurocognitive outcomes among LAMP children
and term-born children. Gestational age (GA) and birthweight are closely related, and
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birthweight can be used as a proxy for GA (Taylor, 2010). Essentially, low birthweight (LBW)
suggests either prematurity, intrauterine growth restriction/fetal growth restriction, or both
(Cutland et al., 2017). LBW is less than 2500g (World Health Organization, 2014). Even
marginally LBW has been associated with lower cognitive scores, including lower verbal
comprehension IQ, lower visual-motor integration, and lower attention performance by schoolage (Starnberg et al., 2018). Therefore, rather than controlling for birthweight, this hypothesis
looked at birthweight as a moderator that is related to both gestational age and neurocognitive
outcomes.
8a. It was predicted that there would be a significant interaction effect between
birthweight and gestational age (birthweight was used as a moderator) in predicting symptom
severity.
8b. It was predicted that there would be a significant interaction effect between
birthweight and gestational age (birthweight was used as a moderator) in predicting
neurocognitive performance across each domain (attention, working memory, executive
functioning, and processing speed).
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Chapter 3: Methods
Participants
Table 2 provides demographic information about the 169 patients represented in this
study. The study utilized de-identified patient data collected between 2014 and 2021 from a
major metropolitan health system. Patients ranged from 8.01 to 12.95 years in age, with good
representation across years. The final sample included nearly twice as many male identifying
subjects as female, which is in keeping with the literature that says males are more likely to be
identified as having attention problems and referred for evaluation (American Psychiatric
Association, 2013). There was a significant representation of non-white participants, including
25% who identified as being Black/African American, resulting in a highly diverse sample that
was consistent with the health system’s urban city demographics (US Census Bureau, 2019).
Prior to their scheduled neuropsychological evaluations, patients’ caregivers were not given
specific/standardized instructions regarding ADHD medication administration on the day of
evaluation; caregivers were allowed to decide whether they wanted results that would reflect
their child’s abilities while on ADHD medication or off ADHD medication. Therefore, ADHD
medication was captured in two ways: current prescription for ADHD medication and ADHD
medication taken on the day of evaluation.
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Table 2
Patient Demographics

Age

M

SD

Range

10.54

1.34

8.01-12.95

n (%)

8 (8.00-8.99)

28 (16.57)

9 (9.00-9.99)

36 (21.30)

10 (10.00-10.99)

33 (19.53)

11 (11.00-11.99)

45 (26.63)

12 (12.00-12.99)

27 (15.98)

LAMP

10.46

1.29

8.05-12.95

Moderately preterm

10.43

1.41

8.05-12.56

Late preterm

10.46

1.27

8.29-12.95

10.59

1.37

8.01-12.81

Early term

10.60

1.31

8.01-12.72

Full term

10.59

1.40

8.17-12.81

Term born

LAMP

Term Born

Total

n (%)

n (%)

Sample
n (%)

Gender
Female

29 (42.03)

22 (22.00)

51 (30.18)

Male

40 (57.97)

78 (78.00)

118 (69.82)

0 (0.00)

0 (0.00)

0 (0.00)

Trans/nonbinary/other
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Table 2 continued
LAMP

Term Born

Total

n (%)

n (%)

Sample
n (%)

Race/ethnicity
American Indian/Alaskan Native

0 (0.00)

0 (0.00)

0 (0.00)

Asian

1 (1.45)

2 (2.00)

3 (1.78)

20 (28.99)

23 (23.00)

43 (25.44)

0 (0.00)

0 (0.00)

0 (0.00)

43 (62.32)

58 (58.00)

101 (59.76)

Latino/Hispanic

2 (2.90)

7 (7.00)

9 (5.33)

Biracial/Mixed

3 (4.35)

6 (6.00)

9 (5.33)

Right

56 (81.16)

84 (84.00)

140 (82.84)

Left

9 (13.04)

10 (10.00)

19 (11.24)

Ambidextrous

4 (5.80)

6 (6.00)

10 (5.92)

ADHD

33 (47.83)

45 (45.00)

78 (46.15)

Anxiety

15 (21.74)

31 (31.00)

46 (27.22)

Depression

9 (13.04)

15 (15.00)

24 (14.20)

Learning disability

9 (13.04)

6 (6.00)

15 (8.88)

Language disorder

6 (8.70)

2 (2.00)

8 (4.73)

Black/African American
Native Hawaiian/Pacific Islander
White

Handedness

Previous psychiatric diagnosis (by history)
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Table 2 continued
LAMP

Term Born

Total

n (%)

n (%)

Sample
n (%)

Participation in early intervention services

25 (36.23)

21 (21.00)

46 (27.22)

Early On

15 (21.74)

8 (8.00)

23 (13.61)

Speech and language pathology (SLP)

21 (30.44)

15 (15.00)

36 (21.30)

Occupational therapy (OT)

6 (8.70)

7 (7.00)

13 (7.69)

Physical therapy (PT)

4 (5.80)

5 (5.00)

9 (5.33)

Current prescription for ADHD medication

24 (34.78)

39 (39.00)

63 (37.28)

ADHD medication on day of evaluation

17 (24.64)

31 (31.00)

48 (28.40)

IEP

24 (34.78)

23 (23.00)

47 (27.81)

504

8 (11.59)

9 (9.00)

17 (10.06)

8 (11.59)

12 (12.00)

20 (11.83)

15 (21.74)

22 (22.00)

91 (53.85)

32 (46.38)

59 (59.00)

37 (21.89)

22 (31.88)

19 (19.00)

41 (24.26)

ADHD Medication

Special education services

Repeated a grade
Caregivers Education Level
Primary/secondary school
One or more caregivers has higher level
education
Unknown
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Table 2 continued
LAMP

Term Born

Total

n (%)

n (%)

Sample
n (%)

Insurance
Medicaid

29 (42.03)

33 (33.00)

62 (36.69)

Commercial

39 (56.52)

66 (66.00)

105 (62.13)

4 (5.80)

15 (15.00)

19 (11.24)

Bilingual or secondary language

Inclusion Criteria
The proposed study utilized a representational sample of 8- to 12-year-old children
previously seen for a neuropsychological evaluation. This age group was chosen owing to the
relative reliability of cognitive findings (Moser et al., 2017). Furthermore, the greatest predictor
of an ADHD diagnosis is the child’s behavior relative to other children of the same age/grade,
often via teacher observation and report (Layton et al., 2018). Children in the identified age
range had multiple years of schooling and therefore opportunity for teachers to have raised
concerns regarding functional impairment caused by potential ADHD symptoms. However, as
previously demonstrated, significant changes by domain, especially in executive functioning
including attention and working memory, occur from middle childhood to adulthood. ADHDrelated neurocognitive deficits may affect symptom presentation as well as cognitive and
academic performance across the school years (Ang & Lee, 2008; Gow et al., 2011; Gur et al.,
2012). The goal was to recruit a roughly equivalent number of male and female subjects and
controls, with a total recruitment goal of 200 children (100 LAMP born children, and 100 full-
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term children); however, there were reductions in outpatient evaluation volume (i.e., furlough)
owing to the COVID-19 pandemic and, consequently, there were fewer patient files to review for
potential inclusion in the study.
Exclusion Criteria
Any child with a diagnosis of intellectual disability (ID), autism spectrum disorder
(ASD), epilepsy, genetic disorders, other neurodevelopmental disorder or major or mild
neurocognitive disorder due to another medical condition (such as stroke or traumatic brain
injury), when there was anticipated or observed neurological impact, was excluded so that the
relationship between the variables of interest could be observed without significant influence
from radical outliers (i.e., aberrant neurocognitive functioning). GA as determined by caregiver
report was used to exclude children who were born very or extremely preterm (GA < 32 weeks),
or late term (GA > 41 weeks). Any child outside of the identified age range (8 to 12 years old) at
the time of their neuropsychological evaluation was also excluded. Cases assessed prior to 2014
were not included to ensure that the utilized measures would be current and applicable to clinical
practice and research.
Institutional Review Board
An Institutional Review Board (IRB) application was submitted for the present study to
the health system where electronic records were to be pulled. An expedited review was
completed, and the study was deemed exempt (see Appendix B). The IRB application required
CITI training for anyone involved in the research study. The primary investigator (author of the
present document) worked within the health system as a research affiliate; in this role, the
primary investigator also applied for and was granted remote access to the EMR and secure drive
so that work could be conducted in a safe off-site location. A second IRB application was
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completed with Eastern Michigan University. This ensured that there was approval for the author
of the present document to conduct analyses and complete dissertation work in partial fulfillment
of the requirements for the degree of Doctor of Philosophy in Clinical Psychology.
Screening
Stage 1: Preliminary Screening. Pediatric neuropsychologists on staff in the Division of
Neuropsychology in a major metropolitan healthcare system provided a list of the cases they had
supervised/conducted since 2014. There were three such supervisors; in total, they turned over a
pool of 9,382 patients to be screened for inclusion. This list included ages and diagnostic status
at the time of evaluation. A research assistant screened for eligible participants by sorting those
between 8 and 12 years old who were not excluded by diagnostic status (e.g., ID, ASD, epilepsy,
genetic disorders, other neurodevelopmental disorder, or major or mild neurocognitive disorder).
These potential subjects were put into a file that contained their identifying information,
including their medical record number (MRN).
Stage 2: EMR Initial Screening. Once subjects were identified in Stage 1 screening,
their electronic medical record was reviewed. Subjects whose GA was not reported, who did not
complete an intake form, or who did not complete a battery of performance-based
neuropsychological tests (including a Wechsler cognitive test) and a behavioral rating scale,
were screened out. Any child whose caregiver reported that they were born prior to 32 weeks’
gestation, or at/after 41 weeks’ gestation, was also excluded from the study. The remaining
subjects were therefore screened for inclusion and exclusion criteria and were ready for data
entry. The final subject pool included 169 children (69 LAMP and 100 term-born children).
Stage 3: Final Screening and Data Entry. Relevant data were pulled from the EMR for
data entry (e.g., patient history form, neuropsychological evaluation report, and testing data
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summary sheet). Subjects’ data were stored in a corresponding folder on a secure shared drive
owned by the health system. Each subject’s file was reviewed, and relevant variables were
entered into the database (also stored on the secure shared drive). After the data were entered, it
was double checked to ensure accuracy. After this two-step entry/check procedure, the copy of
the patient file was deleted from the secure shared drive. The file that linked the patient via MRN
to the database was deleted so that the database no longer contained any identifying information.
Measures
Children presenting for neuropsychological evaluation were accompanied by
parents/caregivers who completed paperwork including a patient history questionnaire and a
social/emotional/behavioral rating scale(s). Children had completed performance-based
neuropsychological testing. Notably, the hospital suspended outpatient neuropsychological
evaluations between March 2020 and June 202 owing to the COVID-19 pandemic (i.e.,
furlough). Evaluations completed after the furlough, between June 2020 and January 2021, were
completed in the context of the ongoing COVID-19 pandemic; as such, both the examiner and
the patient wore a face mask throughout testing. Efforts were made to maintain social distancing
within the testing environment, and a plexiglass barrier separated examiner and patient. Use of a
face mask during administration of in-person measures is an adaptation of standardized
administration, which was considered in the interpretation of results. All scores derived from
behavior rating scales and performance-based neuropsychological measures are age and gender
normed, and, therefore, additional consideration for age and gender as covariates was not
necessary. Diagnostic impressions were taken from the completed neuropsychological evaluation
reports.
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Prenatal, Perinatal, and Other Background History from Patient History Form
Parents/caregivers completed a patient history form. This form queried the child’s
history, including early intervention experiences, prenatal factors, perinatal factors, medical
history, and family history. It is also where caregivers reported on demographic factors such as
race, Medicaid status, and parent educational level, presented in Table 2. Table 3 presents a
summary of relevant medical history and background information taken from the patient history
form. Notably, the current sample had a 51.5% hereditary risk for ADHD. Furthermore, nearly 1
in 10 of the patients were born to caregivers experiencing pre-eclampsia, nearly 1 in 20 had inutero exposure to substances (cigarettes, alcohol, or illegal substances), and 1 in 20 required
intensive care at the time of birth. Taken together, the sample was comprised of children with
multiple significant risk factors for ADHD and other neurodevelopmental concerns, consistent
with what would be expected in a clinical setting where patients are referred by providers and/or
pre-authorized for the evaluation by their insurance company owing to established
risk/probability.
Table 3
Patient Prenatal and Perinatal History
M

SD

Range

37.40

2.27

32-40

35.04

1.32

32-36

69 (40.83)

Moderately preterm

33.00

0.94

32-34

17 (10.06)

Late preterm

35.71

0.46

35-36

52 (30.77)

39.02

1.03

37-40

100 (59.17)

37.68

0.48

37-38

31 (18.34)

Gestational age
LAMP

Term born
Early term

n (%)
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Table 3 continued
M

SD

Range

n (%)

Full term

39.62

0.49

39-40

69 (40.83)

Birthweight (ounces)

108.91

22.52

45-162

93.25

21.69

45-145

Moderately preterm

78.18

20.03

45-111

Late preterm

98.27

19.97

53-145

120.12

15.31

74-162

Early term

115.10

15.04

74-142

Full term

122.55

14.95

86-162

29.49

6.33

16-48

29.51

6.43

16-45

Moderately preterm

28.82

7.05

19-43

Late preterm

29.75

6.27

16-45

29.47

6.29

16-48

Early term

27.94

5.56

20-38

Full term

30.18

6.52

16-48

LAMP

Term born

Mother's age at delivery
LAMP

Term born

LAMP

Term Born

Total

n (%)

n (%)

Sample
n (%)

Medication during pregnancy
Anti-seizure

0 (0.00)

1 (1.00)

1 (0.59)

Anti-depressant

6 (8.70)

1 (1.00)

7 (4.14)
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Table 3 continued
LAMP

Term Born

Total

n (%)

n (%)

Sample
n (%)

Anti-anxiety

1 (1.45)

2 (2.00)

3 (1.78)

Thyroid

4 (5.80)

3 (3.00)

7 (4.14)

12 (17.39)

15 (15.00)

27 (15.98)

Bleeding

5 (7.25)

4 (4.00)

9 (5.33)

Gestational diabetes

4 (5.80)

8 (8.00)

12 (7.10)

High blood pressure/toxemia

9 (13.04)

0 (0.00)

9 (5.33)

Infection

2 (2.90)

1 (1.00)

3 (1.78)

Seizure

1 (1.45)

1 (1.00)

2 (1.18)

Injury/accident

3 (4.35)

0 (0.00)

3 (1.78)

Hospitalization

8 (11.59)

4 (4.00)

12 (7.10)

German measles/Rubella

0 (0.00)

0 (0.00)

0 (0.00)

Placenta abruptia

2 (2.90)

1 (1.00)

3 (1.78)

Placenta previa

1 (1.45)

2 (2.00)

3 (1.78)

Pre-eclampsia

13 (18.84)

3 (3.00)

16 (9.47)

Rh incompatibility

1 (1.45)

3 (3.00)

4 (2.37)

Chronic illness

9 (13.04)

4 (4.00)

13 (7.69)

Major life stress

2 (2.90)

4 (4.00)

6 (3.55)

14 (20.29)

11 (11.00)

25 (14.79)

Other
Complications during pregnancy

Other
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Table 3 continued
LAMP

Term Born

Total

n (%)

n (%)

Sample
n (%)

In-utero exposure to substances

11 (15.94)

11 (11.00)

22 (13.00)

Cigarettes

9 (13.04)

7 (7.00)

16 (9.5)

Alcohol

3 (4.35)

2 (2.00)

5 (3.0)

Illegal substances

4 (5.80)

4 (4.00)

8 (4.73)

Blue at birth

2 (2.90)

2 (2.00)

4 (2.37)

Breech

1 (1.45)

5 (5.00)

6 (3.55)

Cord around neck

4 (5.80)

12 (12.00)

16 (9.47)

Fetal distress

4 (5.80)

5 (5.00)

9 (5.33)

Group B streptococcus

2 (2.90)

1 (1.00)

3 (1.78)

20 (30.00)

27 (27.00)

47 (27.81)

2 (2.90)

0 (0.00)

2 (1.18)

18 (26.09)

12 (12.00)

30 (17.75)

1 (1.45)

2 (2.00)

3 (1.78)

Premature labor

21 (30.43)

0 (0.00)

21 (12.43)

Prolonged labor

1 (1.45)

6 (6.00)

7 (4.14)

Slow heart rate

4 (5.80)

4 (4.00)

8 (4.73)

Other

9 (13.04)

7 (7.00)

16 (9.47)

Labor complications

Induced
Intrauterine growth restriction
Jaundice
Meconium staining
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Table 3 continued
LAMP

Term Born

Total

n (%)

n (%)

Sample
n (%)

Delivery
Vaginal

41 (59.42)

68 (68.00)

109 (64.5)

Caesarean section

27 (39.13)

32 (32.00)

59 (34.91)

26 (37.68)

10 (10.00)

36 (21.3)

Incubator

11 (15.94)

4 (4.00)

15 (8.88)

Bili lights

17 (24.64)

8 (8.00)

25 (14.79)

Oxygen

8 (11.59)

8 (8.00)

16 (9.47)

Transfusion

0 (0.00)

0 (0.00)

0 (0.00)

Other

2 (2.90)

2 (2.00)

4 (2.37)

ADHD

36 (52.20)

51 (51.00)

87 (51.50)

Anxiety

31 (44.90)

49 (49.00)

80 (47.34)

Depression

41 (59.40)

68 (68.00)

109 (64.50)

Intellectual disability

11 (15.90)

7 (7.00)

18 (10.65)

Language disorder

8 (11.60)

3 (3.00)

11 (6.51)

Learning disability

31 (44.90)

23 (23.00)

54 (31.95)

Birth defects

1 (1.40)

5 (5.00)

6 (3.55)

Structural brain abnormality

1 (1.40)

0 (0.00)

1 (0.59)

Intensive care

Family history
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ADHD Diagnosis
Diagnosis of ADHD was determined by diagnostic impressions indicated in the
comprehensive neuropsychological evaluation. Neuropsychologists determined ADHD diagnosis
using DSM-5 diagnostic criteria based on all available sources of information (e.g., clinical
interview, patient history form, behavior rating scales, behavioral observations during evaluation,
performance-based measures of neurocognition, etc.). Therefore, participants in the present study
were coded as having an ADHD diagnosis if that diagnosis had been given following
comprehensive neuropsychological evaluation; if a caregiver reported a history of ADHD, but
the results of the evaluation did not support this diagnosis (i.e., no ADHD diagnosis given), the
participant was coded as having a history of ADHD but not a current diagnosis. Table 4 shows
prevalence of ADHD diagnosis in the present sample, following comprehensive
neuropsychological evaluation, including rates of ADHD diagnosis among the LAMP and termborn groups.

Table 4
ADHD and Other DSM-5 Diagnostic Outcomes

ADHD diagnosis
Predominantly inattentive presentation
Predominantly hyperactive/impulsive presentation
Combined presentation

Total sample

LAMP

Term-born

n (%)

n (%)

n (%)

130 (76.9)

55 (79.7)

75 (75)

35 (20.7)
1 (0.6)
94 (55.6)

NEUROCOGNITION IN CHILDREN BORN LAMP

58

ADHD-Related Symptom Severity as indicated by Behavior Rating Scales
Behavioral reports are also a critical part of school-aged assessment for ADHD,
especially considering that the diagnosis is made based on observed behaviors. ADHD subtype
and severity are also captured by different scales included within measures. Caregivers of all the
children in the sample were administered the school-age form of one or both of the following
measures: The Conners (3rd Ed.; Conners-3; Conners, 2008) and the Behavior Assessment
System for Children (3rd Ed.; BASC-3; Reynolds & Kamphaus, 2015). For purposes of this
study, across behavioral reports, caregivers report on the Attention Problems, Inattention,
Hyperactivity/Impulsivity, and DSM ADHD subscales (Conners-3 only) were used to represent
ADHD symptom severity in the analyses. For both measures, across behavioral reports, raw
scores were converted to t-scores based on the norms from the standardization sample.
The BASC-3 is a behavior rating form that assesses a broad range of emotions and
behaviors via caregiver completion of the child form (ages 6-11 years, 175 items) or adolescent
form (ages 12-21, 173 items). Caregivers are instructed to rate the frequency of their child’s
behavior over the course of the last several months scale (never, sometimes, often, almost
always). In the present study, 118 caregivers completed the BASC-3 behavior rating form. The
Conners-3 is a behavior rating form for children between the ages of 6 and 18 years and was
developed specifically to assess for attentional deficits and symptoms related to ADHD. It comes
in two forms: the full-length form has 110 items and yields all content scales and symptom scales
that capture DSM symptomatic criteria (this includes the DSM ADHD Inattentive subscale and
the DSM ADHD Hyperactive/Impulsive subscale), while the short form has 45 items and yields
content scales but does not include those clinical subscales aligned with the DSM criteria.
Caregivers are instructed to rate the frequency of their child’s behavior over the course of the last
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month on a Likert scale ranging from 0 = not true at all (never, seldom), to 3 = very much true
(very often/very frequently). In the present study, 111 caregivers completed the Conners-3
behavior rating form.
Neuropsychologists chose whether to administer one or more of these rating forms (and
may have administered other behavior rating forms not utilized for the purpose for this study); as
such, 74 caregivers in the current sample completed both the BASC-3 and the Conners-3
behavior rating scales. The BASC-2 Attention problems subscale was previously found to be
strongly correlated with the Conners-3 Inattention subscale (.72, p < .01), and the BASC-2
Hyperactivity subscale was also strongly correlated with the Conners-3
Hyperactivity/Impulsivity subscale (.77, p < .01). As such, to maximize the number of
participants with caregiver-rated symptom severity, a variable called Inattention Combined
Measures was created using the Conners-3 Inattention score and, in the case that the Conners-3
had not been administered, the BASC-3 Attention Problems score. Similarly, a variable called
Hyperactivity Combined Measures was created using the Conners-3 Hyperactivity/Impulsivity
score, in the case that the Conners-3 had not been administered, the BASC-3 Hyperactivity
subscale.
Using a threshold of α = .70 (Santos, 1999), all measures utilized had an acceptable
internal consistency per values reported in their manuals (α = .84–.99). In larger samples
involving more than 30–40 participants, research supports that the sampling distribution has a
tendency toward normalcy regardless of the shape of the data (Ghasemi & Zahediasl, 2012) and
therefore, parametric tests can be justified even when the data deviate from a normal distribution
(Field, 2009). A range of alpha coefficients is provided from the manuals of respective measures;
this range shows purported alpha coefficients for children between the ages of 8 and 12 years, on
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those subscales that were utilized in the present study (Conners, 2008; Reynolds & Kamphaus,
2015); alpha coefficients were not calculated using study data because only standard scores from
behavior rating scales were available for analyses (i.e., individual items on behavior rating scales
were not available). Descriptive statistics for this sample on all behavioral rating scale indicators
of symptom severity appear in Table 5.
Table 5
Descriptive Statistics for Symptom Severity as Indicated by Behavior Rating Scales
Construct Subscale

N

M

SD

Range

α

Attention problems (BASC-3)

118

64.53

10.08

33-84

.88-.91

Inattention (Conners-3)

111

77.37

11.62

35-90

.91-.94

Inattention Combined Measures

155

73.93

12.48

35-90

Hyperactivity (BASC-3)

118

63.00

13.88

35-92

.84-.89

Hyperactivity/Impulsivity (Conners-3)

111

73.32

15.59

38-90

.93-.95

Hyperactivity Combined Measures

155

70.39

15.75

35-92

98

75.60

12.48

40-90

.92-.93

98

71.94

15.64

38-90

.89-.93

Problems with Attention

Behavioral Hyperactivity

DSM Indicators for ADHD
DSM ADHD Inattentive (Conners-3)
DSM ADHD Hyperactive/Impulsive
(Conners-3)

Attention Problems. On the BASC-3 Parent Rating Scales, patients’ mean attention
problems fell in the “At-Risk” range, with scores ranging from “Acceptable”/within normal
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limits (WNL) to “Clinically Significant.” Mean problems with inattention, as reported on the
Conners-3 Parent Form, fell in the “Very Elevated” range, and ranged from “Average or
Below”/WNL to “Very Elevated.” In addition, 33.1% (56 of 169) of the patients included in this
sample were identified as having clinically significant attention problems by one or both
measures (T > 70).
Hyperactivity/Impulsivity. On the BASC-3 Parent Rating Scales, patients’ mean
hyperactivity problems fell in the “At-Risk” range, with scores ranging from
“Acceptable”/within normal limits (WNL) to “Clinically Significant.” Mean problems with
hyperactivity and/or impulsivity, as reported on the Conners-3 Parent Form, fell in the “Very
Elevated” range, and ranged from “Average or Below”/WNL to “Very Elevated.” 27.2% (46 of
169) of the patients included in this sample were identified as having clinically significant
problems with hyperactivity/impulsivity by one or both measures (T > 70).
DSM ADHD Problems. The two symptom scales utilized in the present study include
the DSM ADHD Inattentive subscale and the DSM ADHD Hyperactive/Impulsive subscale. Both
of these scales were originally created to correspond with the ADHD diagnostic criteria in the
Diagnostic and Statistical Manual of Mental Disorders (4th ed.; Text rev.; DSM-IV-TR). After
the DSM-5 was published, a manual update was provided to scoring and interpretation of these
clinical subscales; the only change that pertains to the present sample was that the subscale
names were updated to reflect the reclassification of subtype presentations (e.g., predominantly
inattentive presentation, predominantly hyperactive/impulsive presentation, and combined
presentation). Items included on these subscales approximate symptom-level criteria from the
DSM, but do not capture full diagnostic criteria (Conners, 2014a). Caregivers report at the item
level determined whether a specific symptom was indicated (2 = pretty much true, 3 = very much
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true), may be indicated (2 = pretty much true), or not indicated (1 = just a little true, 0 = not true
at all).
Scores on the DSM-5 ADHD Inattentive scale ranged from “Average or Below”/WNL to
“Very Elevated,” with a mean score in the “Very Elevated” range. Furthermore, 40.24%
(68/169) of the sample was identified as having clinically significant risk for ADHD using the
DSM-5 ADHD Inattentive scale. Scores on the DSM-5 ADHD Combined scale ranged from
“Average or Below”/WNL to “Very Elevated,” with a mean score in the “Very Elevated” range.
About one third (33.14%; 56/169) of the sample were identified as having clinically significant
risk for ADHD using the DSM-5 ADHD Combined scale. Though the BASC-3 has a similar
clinical subscale of DSM-based ADHD Probability, this score was not available for review in
this sample.
Neuropsychological Measures
To maximize the number of participants and minimize missing data, neuropsychological
tests that measure the same construct and are highly intercorrelated were used interchangeably
(i.e., multiple measures used as singular variable for construct of interest). Descriptive statistics
for neuropsychological measures appear in Table 6.
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Table 6
Descriptive Statistics for Neuropsychological Measures
Construct

Measure

N

M

SD

Range

g/IQ

WISC-V FSIQ

169 93.37 12.20

64-146

Sustained attention

CPT-2/CPT 3 Omissions

167 60.15 14.83

40-109

Impulsivity

CPT-2/CPT 3 Commissions

167 53.19

7.83

31-70

Brief attention

WISC-V DSF

168

8.34

2.46

3-14

Spatial revisualization

WISC-V DSB

168

8.45

2.96

1-17

Auditory memory

WISC-V DSS

168

8.81

3.03

1-18

140

8.39

3.84

1-16

D-KEFS TMT-4

112

8.10

3.80

1-16

Trails B

28

9.00

4.15

1-14

127

8.80

3.40

1-16

D-KEFS CWIT-3

101

9.23

3.11

1-15

NEPSY Inhibition

26

7.12

3.95

1-16

126

9.58

3.07

1-16

D-KEFS CWIT-4

101

9.98

2.87

1-16

NEPSY Inhibition-Switching

25

7.96

3.37

1-15

WISC-V PSI

168 94.64 14.80

Attention

Working memory

Executive functioning
Cognitive flexibility

Inhibition

Inhibition with switching

Processing speed

56-132
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g/IQ. The Wechsler Intelligence Scale for Children (5th ed.; WISC-V; Wechsler, 2014)
provides an estimate of overall cognitive functioning: the Full-Scale IQ (FSIQ). The FSIQ is a
composite derived from performance across domains of verbal comprehension, visual spatial
processing, fluid reasoning, working memory, and processing speed. It is considered the most
reliable score and most representative of general intellectual functioning (g) (Wechsler, 2014).
See Appendix C further information on psychometric properties. In the present sample, the mean
g/IQ, estimated by the WISC-V FSIQ, was in the average range, although slightly below the
population mean of 100 and SD of 15. Patients’ performance ranged from impaired to very
superior. The FSIQ was interpreted by the attending clinician in conjunction with other test data
and background information to determine diagnostic status (e.g., intellectual disability), which
was used to determine if the patient could be included in the present study.
Attention. Attention is a complex neurocognitive construct. In assessment, it is typically
measured via selective and sustained attention as well as brief attentional capacity. Regarding
formal measures of attention, the Conners Continuous Performance Test (2nd ed. and 3rd ed.;
CPT-2 and CPT-3) are commonly used diagnostic tools in ADHD (Conners, 2014; Dupaul et al.,
1992; Nichols & Waschbusch, 2004; Rapport et al., 2000). This test measures sustained attention
to visual stimuli and response inhibition over time. Respondents sit at a computer, watch the
screen, and press the space bar for every letter that flashes on the screen except for the letter x.
Scores on the CPT-2/CPT-3 include omissions and commissions, which reportedly indicate
inattention and impulsivity, respectively. These two scores are represented by t-scores with a
mean of 50 and SD of 10. Both DS-F and the Conners CPT-2/CPT-3 demonstrate excellent
psychometric properties (see Appendix D further information on psychometric properties) and
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will be used as a measure of sustained attention as indicated by omissions and commissions. The
Digit Span Forward (DS-F) subtest of the WISC-V provides some indication of brief attentional
capacity. The DS-F requires the subject to repeat back increasingly longer strings of numbers
presented to them. The subtest has a mean scaled score of 10 and SD of 3. DS-F will be used as a
measure of brief attention.
In the present sample, patients’ mean performance on the CPT-2/CPT-3 was
characterized by a high-average rate of omission errors; analysis of patients’ performance shows
that 41.92% had an elevated or very elevated rate of omission errors. Patients’ mean performance
on a measure of impulsivity was characterized by an average rate of commission errors; analysis
of patients’ performance shows that 20.96% had an elevated or very elevated rate of commission
errors. Patients’ brief attention as measured by performance on the WISC-V Digit Span Forward
subtest fell in the average range. Analysis of patients’ performance found that 35.1% of the
sample performed below the average range (impaired, borderline impaired, or low average).
Working Memory. Working memory is the ability to hold and manipulate information
in the mind (Cowan & Alloway, 2009). The WISC-V includes a Working Memory Index (WMI)
that was designed in accordance with Baddeley’s multi-component model of memory (A.
Baddeley, 2000, 2003; Baddeley et al., 2011). The WMI on the WISC-V is composed of two
subtests: Digit Span (consisting of Digit Span Forward, Backward, and Sequencing) and Picture
Span. Digit Span Forward is a measure of brief auditory attention, while Backwards and
Sequencing are measures of working memory (notably backwards includes spatial
revisualization, and sequencing requires auditory acoustic memory). Picture Span requires the
child to remember visually presented stimuli (i.e., familiar objects) and identify them in sequence
among non-targets. The child can receive partial credit for correctly identifying targets from non-
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targets, despite incorrect sequence in identification. Therefore, the strongest measure of working
memory from either WMI, as it is classically defined, is Digit Span Backwards (DS-B) and
Sequencing (DS-S). On DS-B, the respondent is read increasingly longer strings of numbers and
asked to recite them backwards. DS-S requires the respondent to put the presented numbers in
sequence, from smallest to largest. These subtests have a mean scaled score of 10 and SD of 3.
DS-B and DS-S demonstrate good psychometric properties and were used as a measure of
working memory with spatial revisualization and auditory acoustic memory (see Appendix D
further information on psychometric properties).
In this sample, patients’ mean score on measures of working memory (WISC-V DSB and
DSS) fell in the average range. On a measure of working memory and spatial revisualization,
36.9% of patients performed below the average range (impaired, borderline impaired, or low
average). On a measure of working memory and acoustic memory, 31.5% of patients performed
below the Average range.
Executive Functioning. Executive functioning broadly refers to higher order cognitive
processes involved in formulating goals, planning, organization, and performance maintenance
(Lezak et al., 2012). The most comprehensive battery for measuring executive functioning is the
Delis-Kaplan Executive Function System (D-KEFS; Shunk et al., 2006). It includes several
subtests that measure discrete aspects of executive functions. Commonly used subtests included
in neuropsychological assessment of school-aged children presenting for concerns related to
ADHD include the Trail Making Test Condition 4 (TMT 4), which measures sequencing and
shifting/cognitive flexibility. The Trail Making Test Part B (TMT B) is an alternate version, and
it is interchangeable with D-KEFS TMT 4. The main difference between these two versions is
the normative data. TMT B utilizes normative data from 1997, while TMT 4 utilizes normative
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data from 2006. Both trail-making tests require the respondent to alternate connecting numbers
and letters in sequential order by making pencil lines between the encircled stimuli on a page.
TMT 4 is a subtest with a mean score of 10 and SD of 3. TMT B yields a z-score with a mean
score of 0 and SD of 1. For ease of comparison, TMT B was transformed into a scaled score with
a mean of 10 and SD of 3 so that it could easily be compared to TMT 4. D-KEFS TMT and TMT
B demonstrate good psychometric properties and were used as measures of cognitive flexibility
(see Appendix D further information on psychometric properties).
The Color Word Interference Test (CWIT) is another D-KEFS subtest used to assess
neurocognitive concerns related to ADHD, and it measures inhibition and cognitive flexibility.
There are two parts to CWIT. On the CWIT inhibition (CWIT I) task, the respondent is presented
with color names printed in a different colored ink, and they must inhibit reading the word and
instead name the dissonant ink color in which the word is printed. In CWIT inhibition with
switching (CWIT IS), the respondent must switch back and forth between naming the dissonant
ink color and reading the word. CWIT I and CWIT IS yield scaled scores with a mean of 10 and
SD of 3 (see Appendix D further information on psychometric properties).
Alternatively, a clinician may choose to measure inhibition and inhibition with cognitive
flexibility using the NEPSY Inhibition test, which includes an Inhibition Condition and
Switching Condition parallel to the D-KEFS Inhibition and Inhibition with Switching. However,
the NEPSY Inhibition may be more appropriate for children with dyslexia or reading difficulties,
or who have color blindness, as the stimuli are white and black arrows rather than words. In the
Inhibition condition, the respondent must say “up” when the arrow is pointing down and say
“down” when the arrow is pointing up. In the Switching Condition, the respondent must switch
between saying the dissonant direction and saying the correct direction depending on whether the
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arrow is black or white. The NEPSY Inhibition test yields scaled scores with a mean of 10 and
SD of 3 for both conditions. Per the manual, the NEPSY Inhibition test shows a consistent
moderate relationship with the D-KEFS CWIT; CWIT I and NEPSY Inhibition Condition
showed a .43 correlation, and CWIT IS and NEPSY Inhibition Switching Condition have a .57
correlation (Delis et al., 2001; Homack et al., 2005; Korkman et al., 2007). The D-KEFS CWIT
and NEPSY Inhibition test demonstrate good psychometric properties and were used as measures
of inhibition with cognitive flexibility (see Appendix D further information on psychometric
properties).
In this sample, patients’ mean performance was in the average range on all subtests from
the DKEFS Trail Making Test (TMT) and the Color-Word Interference Test (CWIT). Mean
performance was in the low-average range on a measure of cognitive flexibility (NEPSY
Inhibition) and was in the average range on a measure of inhibition with switching (NEPSY
Inhibition with Switching). As previously mentioned, neuropsychological tests that measure the
same construct and are highly intercorrelated were used interchangeably. As such, certain
subtests were collapsed into the following single variables: Cognitive Flexibility (D-KEFS TMT
4 or Trails B), Inhibition (D-KEFS CWIT 3 or NEPSY Inhibition), and Inhibition with Switching
(D-KEFS CWIT 4 or NEPSY Inhibition with Switching). Mean overall cognitive flexibility,
inhibition, and inhibition with switching all fell in the average range.
Processing Speed. Processing speed is a component of executive functioning that refers
to the speed with which an individual can process information and react to it meaningfully. The
WISC-V includes a Processing Speed Index (PSI) composite score derived from performance on
two subtests: Coding and Symbol Search. Speed of information processing is the target variable
measured by each of these subtests. However, notable non-target factors can account for variance
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in performance. Coding requires graphomotor dexterity in drawing symbols into boxes based on
a key, and performance on this test can be significantly negatively impacted by fine motor
deficits. Symbol Search requires visual scanning in finding and crossing out targets among nontargets, and performance on this test can be significantly negatively impacted by visual
conditions. Since subjects with neurodevelopmental disorders that include extreme dexterity
issues or visual impairment were screened out of the subject pool, the PSI of the WISC-V was
considered a valid and reliable measure of the target variable (see Appendix D further
information on psychometric properties). The PSI has a mean standard score of 100 with a SD of
15.
In this sample, the mean processing speed as estimated by the WISC-V PSI was in the
average range. Patients’ performance ranged from impaired to very superior. Analysis of
patients’ performance found that 36.9% of the sample performed below the average range
(impaired, borderline impaired, or low-average).
Risk Factors
The present study examined risk factors hypothesized to impact developmental outcomes
including identification as a racial minority, parents’ lack of higher-level education, lower SES
as indicated by Medicaid insurance, genetic heritability as indicated by family history of ADHD,
and any prenatal exposure to substance (including tobacco, alcohol, or other illicit substances).
Each of these risk factors were coded based on caregiver endorsement on the patient history
questionnaire and coded 1 = yes if they endorsed a particular risk factor, and 0 = no if they
denied the presence of that risk factor. See Tables 2 and 3 for additional information. Regarding
parent education level, if the respondent indicated that neither caregiver had higher level
education (defined as anything above a high school diploma, certificate, or GED), that
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participant was coded as having the risk factor (yes) of parents’ lacking higher level education; if
either caregiver was reported to have higher level education, then the participant was coded as
not having the risk factor (no) of parents’ lacking higher level education.
Total Risk Factors. In keeping with Sameroff (2009), a cumulative risk variable was
created from the sum of endorsed risk factors, including identification as a racial minority,
parents’ lack of higher-level education, Medicaid insurance, genetic heritability (family history
of ADHD), and in-utero exposure to substances, for a possible score ranging from 0 to 5. In the
current sample, this cumulative risk score was able to be calculated for n = 128, with a mean of
1.58, and an SD of 1.15. There was not a significant difference in mean cumulative risk between
the LAMP (M = 1.66, SD = 1.09) and term-born groups (M = 1.53, SD = 1.18), t (126) = -.61, p
= .54, d = 1.15.
Symptom Mitigating Factors
Symptom mitigating factors were included as individual and combined covariates in the
analyses. Firstly, caregiver-completed behavior rating scales, including the Behavior Assessment
System for Children (3rd ed.; BASC-3) and Adaptive Behavior Assessment System (3rd ed.;
ABAS-3), were utilized to look at two additional hypothesized symptom-mitigating factors,
specifically social skills and adaptive skills, as measured using specific subscales (see Table 7).
Clinicians could have decided to use either the BASC-3, the ABAS-3, or both, in their
assessment of the child. The BASC-3 subscales are reported in t-scores with an average of 50
and SD of 10. ABAS-3 composites are reported in standard scores with a mean of 100 and SD of
15. (See Appendix E for summary of psychometric properties of behavior rating scales).
Additionally, information regarding participation in early intervention services was pulled from
the patient background and history questionnaire.
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Table 7
Descriptive Statistics for Symptom Mitigating Factors Derived from Behavior Rating Scales
Construct Subscale

N

M

SD

Range

α

Social Skills (BASC-3)

118

44.67

10.86

10-66

.90-.93

Social Composite (ABAS-3)

137

85.94

14.29

52-120

.94-.97

Adaptive Skills (BASC-3)

118

41.21

10.93

10-72

.84-.91

General Adaptive Composite (ABAS-3)

135

83.92

12.95

46-120

.98-.99

Social Skills

Adaptive Skills

Social Skills. The Social Skills subscale of the BASC-3 (derived from caregiver response
on 10 items) and the Social Composite from the ABAS-3 (derived from caregiver response on 26
items) were used as indicators of parent-reported social skills. On the BASC-3 Parent Rating
Scales, patients’ mean social skills fell in the “Acceptable”/WNL range, with scores ranging
from “Clinically Significant” deficit to “Acceptable”/WNL. On the ABAS-3, patients’ mean
Social Composite, which includes leisure and social skills, fell in the “Below Average” range,
with scores ranging from “Extremely Low” to “High.” For this sample, social skills as measured
on the BASC-3 or the ABAS-3 were lower than for the standardized population but still within
the acceptable range. Per cutoffs in their respective manuals (Harrison & Oakland, 2015;
Reynolds & Kamphaus, 2015), children whose caregivers reported their social skills to be in the
average range or higher, on either measure, were coded as having Intact Social Skills (i.e., coded
1 = yes); anyone with a score below this cutoff was coded as lacking this symptom mitigating
factor (i.e., coded 0 = no). More specifically, caregivers who rated social skills at/above a t-
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score of 40 on the BASC-3, or at/above a standard score of 90, were coded as having intact
social skills. Only 37.9% (64/169) of the sample were identified as having intact social skills by
one or both measures.
Adaptive Skills. Adaptive skills were assessed using the General Adaptive Composite
(GAC) score from the ABAS-3 (derived from caregiver response across all subscales/211 items)
and the Adaptive Skills composite of the BASC-3 (derived from caregiver response across all
adaptive scales/46 items). On the BASC-3 Parent Rating Scales, mean adaptive skills fell in the
“Acceptable”/WNL range although lower than the population mean, with scores ranging from
“Clinically Significant” deficit to “Acceptable”/WNL. On the ABAS, patients’ mean Global
Adaptive Composite, which includes conceptual, social, and practical skills, fell in the “Below
Average” range, with scores ranging from “Extremely Low” to “High.” Per cutoffs in their
respective manuals (Harrison & Oakland, 2015; Reynolds & Kamphaus, 2015), children whose
caregivers reported their adaptive skills to be in the WNL/average range or higher, on either
measure, were coded as having Intact Adaptive Skills (i.e., coded 1 = yes); anyone with a score
below this cutoff was coded as lacking this symptom mitigating factor (i.e., coded 0 = no). More
specifically, caregivers who rated adaptive skills at/above a t-score of 40 on the BASC-3, or
at/above a standard score of 90, were coded as having intact adaptive skills. Only 30.2%
(51/169) of the sample were identified as having intact adaptive skills by one or both measures.
Participation in Early Intervention. Participation in an early intervention program was
also included as a mitigating factor in these analyses because the research literature suggests that
participation in early intervention services positively impacts cognitive development (BlauwHospers et al., 2007; Spittle et al., 2015; Vanderveen et al., 2009). Based on caregiver report on
the patient history questionnaire, information was gathered regarding participation in Early On
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(social, health, and educational intervention services for children, birth to age 3 years, who have
developmental delays or are at risk for delays due to certain health conditions), speech therapy
(SLP), occupational therapy (OT), and physical therapy (PT), at/before the age of 5 years. In the
present sample, 13.6% of participants had participated in Early On, 21.3% had received early
SLP, 7.7% had received early OT, and 5.3% had received early PT (see Table 2). A combined
variable was created, called Participation in Early Intervention, and was coded yes/no if the
patient had received any of those early intervention services.
Total Symptom Mitigating Factors. In keeping with Sameroff (2009), a total symptom
mitigating score was created from the sum of endorsed symptom mitigating factors which
included participation in early intervention services, intact social skills, intact adaptive skills.
Possible scores for Total Symptom Mitigating Factors ranged from 0 to 3. In the current sample,
this score was able to be calculated for n = 151, with a mean of 1.21, and an SD of 1.16. There
was no significant difference in mean total symptom mitigating factors between LAMP (M =
1.38, SD = 1.24) and term-born groups (M = 1.09, SD = 1.09); t(149) = -1.49, p = .13, d = 1.15.
Power Analyses
A priori power analyses were conducted, and it was determined that approximately 100
participants in the subject group and the control group would ensure adequate sample size and
statistical power (200 participants). A sample size of approximately 100 participants was deemed
appropriate because the methodology of the study entailed running a moderation model that
would include up to six predictors (risk factors and symptom mitigating factors, as well as the
primary independent variable); the other analyses included an equal number of or fewer
predictors and were adequately powered at less than 100 per group.
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Regarding post-hoc power analyses, effect sizes were provided for all results. Pearson
correlations are described as small if the value of r (|r|) is between .1 and .29, medium if |r| is
between .3 and .49, and large if |r| is equal to or greater than .5 (J. Cohen, 1988). Cohen’s d was
presented for all t-tests, and partial eta squared for all regression analyses. Eta-square are
described using Cohen’s (1988) conventions for small, medium, and large effect sizes, which are
.01, .06, and .14, respectively.
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Chapter 4: Results
Preliminary Data Analyses
Covariate Analysis
Pearson correlations and t-tests were calculated to examine the impact of ADHD
medication as a potential covariate on outcomes (symptom severity as indicated by caregiver
report on behavior rating scales and performance-based measures of neurocognitive functioning).
Significant group differences were found in caregiver report on behavior rating scales between
those children who were prescribed ADHD medication (n = 63, 37% of total sample) and those
who did not have a prescription for ADHD medication. As such, ADHD medication was
accounted through partial correlational analyses and as a control on regression analyses. Owing
to the sample size, it was not possible to run separate t-test analyses subdividing the sample by
whether they had a current prescription for ADHD medication. Regarding performance-based
measures of neurocognitive functioning, no significant group differences were found based on
whether patients had taken ADHD medication on the day of evaluation.
Additional covariates are considered in the primary and experimental analyses. More
specifically, the present study examined the impact of risk factors (e.g., minority status, lack of
parental higher-level education, Medicaid status, genetic heritability, and prenatal exposure to
substances) and potential symptom mitigating factors (e.g., participation in early intervention
services, intact social skills, and intact adaptive skills) on ADHD diagnosis (determined by
neuropsychologist), ADHD symptom severity (determined by caregiver report on behavior rating
scales), and neurocognitive functioning (child performance on neuropsychological measures).
Regarding risk factors, chi-square tests were run to examine difference between expected
and observed risk factors by LAMP status (yes = LAMP, no = term-born) to see if risk factors
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were endorsed at a higher rate among LAMP children. In the current sample, none of the risk
factors were more likely to be found in the history of children born LAMP than among term-born
children. Regarding symptom mitigating factors, chi-square tests were run to examine the
relationship between symptom mitigating factors and LAMP status (yes = LAMP, no = termborn) to see if symptom mitigating factors were endorsed at a higher rate among LAMP children.
There was a significant relationship between participation in early intervention services and
LAMP status, X2 (1, N = 169) = 4.78, p = .04, Cramer’s V = .17. Rate of participation in early
intervention services was significantly different between LAMP children (36.2%) and term-born
children (21.0%), in the current sample. Intact social and adaptive skills were not significantly
different between LAMP and term-born children.
Regarding Hypotheses 4a and 8b, regression diagnostics were run for all relevant
variables in the regression models to evaluate assumptions including linearity, homoscedasticity,
normality, and independence. From the Loess curve, scatterplots demonstrated that the
relationship of standardized predictors to residuals was roughly linear (around zero) and
therefore linearity and homoscedasticity assumptions were satisfied. P-P plots provided visual
confirmation of generally normal distributions. Furthermore, skewness and kurtosis analyses
were run to check for normality. Notably, the Conners-3 Inattention subscale was slightly
negatively skewed (-1.06), and the Conners-3 Hyperactivity/Impulsivity and the Conners-3 DSM
ADHD Hyperactive/Impulsive subscales showed slight platykurtik (-1.07 and -1.14,
respectively). Cook’s distance was used to assess for the presence of influential outliers. None
were found, all Cook’s distance values fell well below the recommended cutoff of 1 (Cook &
Weisberg, 1982), and observations were independent.
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Analyses of Primary Study Hypotheses
Behavior Rating Scales
ADHD Diagnosis and Symptom Severity as Outcome—Hypothesis 1. It was predicted
that there would be a higher prevalence of ADHD and greater ADHD-related symptom severity
among lower GA-groups, specifically LAMP, compared to children born at term (Hypothesis 1ad). T-tests, chi-square tests, bivariate Pearson correlation coefficients (Table 7), and ANOVA
analyses (Table 8) were used to examine the relationship between GA and diagnostic status
(yes/no ADHD as determined by a neuropsychologist), and the symptom severity as indicated by
parent report of attention problems/inattention (BASC-3 Attention Problems subscale; Conners-3
Inattention subscale), hyperactivity/impulsivity (BASC-3 Hyperactivity subscale; Conners-3
Hyperactivity/Impulsivity subscale), and ADHD problems (Conners-3 ADHD Inattentive
subscale; Conners-3 ADHD Combined subscale). Higher scores on parent rating forms of
symptom severity indicate greater problems.
1a. A t-test was used to determine whether the average gestational age (GA) was
different between those children diagnosed with ADHD and those children who were not
diagnosed with ADHD. Those who received an ADHD diagnosis (M = 37.35, SD = 2.29) had a
comparable average GA as those who did not receive an ADHD diagnosis (M = 37.54, SD =
2.26), t(167) = .44, p = .66, d = 2.28. These results suggest that, in this sample, GA is not a
significant predictor to ADHD diagnosis; children with and without ADHD had comparable
mean GAs.
1b. A chi-square test was used to examine the difference between expected and observed
rates of ADHD diagnosis (yes/no) by GA as a categorical variable (late preterm, moderate
preterm, early-term, and full-term). There was not a significant relationship between GA group
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and ADHD diagnostic status, X2 (3, N = 169) = .66, p = .88, Cramer’s V = .06. ADHD rates were
not significantly different across moderate preterm (76.5%), late preterm (80.8%), early term
(74.2%), or term-born groups (76.9%) in the current sample.
1c. Because of observed differences between those with a current prescription for ADHD
medication and those without one on parent completed behavior rating forms, a partial
correlation was completed to account for the impact of ADHD medication on parents’
perceptions of attention difficulties. Results are presented in Table 8.
Table 8
Correlations Between GA and Symptom Severity as indicated by Caregiver Report on Behavior
Rating Scales
Construct

Measure

Bivariate

Partial

Inattention

BASC-3 Attention Problems (n = 118)

-.01

-.03 [-.19, .12]

Conners-3 Inattention (n = 111)

-.16t

-.18t [-.32, -.03]

Inattention Combined Measure (n = 155)

-.09

-.10 [-.23, .43]

.06

.04 [-.12, .19]

Conners-3 Hyperactivity/Impulsivity (n = 111)

-.15

-.17t [-.32, -.01]

Hyperactivity Combined Measure (n = 155)

-.09

-.11 [-.23, .28]

Conners-3 DSM ADHD Inattentive

-.17t

-.18t [-.37, .02]

Conners-3 DSM ADHD Hyperactive/Impulsive

-.15

-.17t [-.35, .01]

Hyperactivity BASC-3 Hyperactivity (n = 118)

DSM ADHD
Problems

t

p < .10 level (2-tailed), BCa bootstrap 90% CIs reported in brackets
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The partial correlations between GA and several behavior rating subscales (Conners-3
Inattention, Conners-3 Hyperactivity/Impulsivity, Conners-3 DSM ADHD Inattentive, and
Conners-3 DSM ADHD Hyperactivity/Impulsivity), including current prescription for ADHD
medication as a covariate, were found to be marginally significantly negatively related. After
adjusting for the effect of a current prescription for ADHD medication on parent report of
ADHD symptom severity, the relationship was slightly strengthened across all Conners-3
subscales. Inattention and hyperactivity/impulsivity, as captured by the Conners-3 Parent rating
form, shows a marginally significant relationship with GA, both before and after controlling for
the impact of a current prescription for ADHD medication; lower GA is related to higher
inattention and hyperactivity/impulsivity, and higher GA was related to lower symptom report.
Symptom severity for inattention and hyperactivity on the BASC-3 showed a completely nonsignificant relationship with GA.
1d. Based on the results of Hypothesis 1c, an ANCOVA was used to determine if there
were statistically significant differences between LAMP and term-born children in attention
problems, specifically those measured by the Conners-3, while controlling for current
prescription for ADHD medication. The covariate, current prescription for ADHD medication,
was significantly related to parents’ report of symptom severity across all subscales of the
Conners-3. There was also a marginally significant effect of LAMP history on parents’ report of
symptom severity as indicated by the Inattention and Hyperactivity/Impulsivity subscales of the
Conners-3 (see Table 9). Interestingly, there were no significant effects of GA on parents’ report
of symptom severity as indicated by the DSM ADHD subscales of the Conners-3 after
controlling for the effect of current prescription for ADHD medication. Having a current
prescription for ADHD medication and a history of LAMP were significant and marginally
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measured by the Conners-3 Inattention and the Hyperactivity/Impulsivity subscales.
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Table 9
ANCOVA for Conners-3 by GA with Current Prescription for ADHD Medication as Covariate
SS

df

MS

F

n2

1016.90

1

1016.90

8.17**

.97

412.82

1

412.82

3.32t

.03

Error

13439.19

108

124.44

Current prescription for ADHD medication

2183.82

1

2183.82

9.91**

.08

803.65

1

803.65

3.65t

.03

23799.62

108

220.37

676.66

1

676.66

4.58*

.05

372.78

1

372.78

2.52

.03

14038.033

95

147.77

Subscale

Source

Inattention

Current prescription for ADHD medication
(covariate)
LAMP status

Hyperactivity/Impulsivity

(covariate)
LAMP status
Error
DSM ADHD Inattentive

Current prescription for ADHD medication
(covariate)
LAMP status
Error
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Table 9 continued
Subscale

Source

DSM ADHD Hyperactive/Impulsive

Current prescription for ADHD medication

SS

df

MS

F

n2

2121.75

1

2121.75

9.56**

.09

498.06

1

498.06

2.24

.02

21082.82

95

221.92

(covariate)
LAMP status
Error
t

p < .10 level (2-tailed)
*p < .05 level (2-tailed)
**p < .01 level (2-tailed)
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Risk Factors Impacting Diagnosis and Symptom Severity—Hypothesis 2. This
hypothesis examined the relationship between several risk factors (race, Medicaid status, parent
educational level, genetic heritability, prenatal exposure to substances) and ADHD in the sample
(Hypotheses 2a-b). Both the global diagnosis of ADHD as determined by a neuropsychologist
and the severity of ADHD symptoms as reported by the parents were examined in relation to
these risk factors. T-tests and chi-square tests were used to examine the relationship between GA
and diagnostic status (yes/no ADHD), and the symptom severity as indicated by parent report of
attention problems/inattention (BASC-3 Attention Problems subscale; Conners-3 Inattention
subscale), hyperactivity/impulsivity (BASC-3 Hyperactivity subscale; Conners-3
Hyperactivity/Impulsivity subscale), and ADHD problems (Conners-3 ADHD Inattention
subscale; Conners-3 ADHD Combined subscale).
2a. Chi-square tests were run to examine difference between expected and observed risk
factors (yes/no) based on diagnostic status (yes/no ADHD). As can be seen in Table 10, no
significant differences were found between expected and observed rates of ADHD diagnosis by
risk factor.
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Table 10
Chi-Square Tests Examining Relationship Between Risk Factors and ADHD Diagnostic Status
Racial Minority

Parents Lacking

Medicaid

Family History

In-utero

Status

Higher-Level

Insurance

of ADHD

Exposure to

Education
n (Yes:No)

Substances

68:101

37:91

62:105

87:82

22:147

X2

.40

1.82

1.74

2.22

2.19

p

.53

.18

.19

.14

.14

Cramer's V

.05

.12

.10

.12

.11

2b. T-tests were run to examine whether mean symptom severity as indicated by
caregivers’ report on behavior rating scales (BASC-3 Attention Problems, Conners-3 Inattention,
BASC-3 Hyperactivity, Conners-3 Hyperactivity/Impulsivity, Conners-3 DSM ADHD
Inattention, Conners-3 DSM ADHD Hyperactive/Impulsive) differed between those who
endorsed risk factors (Yes) and those who did not (No). Risk factors included identification as a
racial minority, parent’s lacking higher-level education, Medicaid insurance, family history of
ADHD, and/or prenatal exposure to substances.
As can be seen in Table 11, those who identified as a racial minority had a marginally
significantly higher mean Conners-3 Inattention problems as those who identified as White.
Overall, being a racial minority was not related to higher symptom report on measures of
attention/inattention, hyperactivity/impulsivity, or ADHD problems; notably, the Conners-3
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Inattention measure may have captured marginally significant variance attributable to racial
identity compared to other measures/subscales.
Table 11
Comparing Mean Symptom Severity by Minority Status
Yes (n = 68)

No (n = 101)

Mean (SD)

Mean (SD)

t

d

BASC-3 Attention Problems

65.91 (10.33)

63.75 (9.91)

-1.12

-.22

Conners-3 Inattention

79.63 (9.08)

75.58 (13.08)

-1.92t

-.35

BASC-3 Hyperactivity

62.72 (14.65) 63.16 (13.52)

0.17

.03

Conners-3 Hyperactivity/Impulsivity

75.45 (14.41) 71.63 (16.38)

-1.29

-.25

Conners-3 DSM ADHD Inattentive

76.98 (12.34) 74.57 (12.60)

-0.94

-.19

74.24 (14.64) 70.21 (16.28)

-1.26

-.26

Subscale

Conners-3 DSM ADHD
Hyperactive/Impulsive
t

p < .10 level (2-tailed)

The absence of parental higher-level educational attainment was not related to parents’
report of behavior rating scales (see Table 12).
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Table 12
Comparing Mean Symptom Severity by Parents Lack of Higher-Level Education

Subscale

Yes (n = 37)

No (n = 91)

Mean (SD)

Mean (SD)

t

d

BASC-3 Attention Problems

64.21 (10.30) 63.02 (10.37) -0.48

-.16

Conners-3 Inattention

76.43 (15.99) 77.74 (10.86)

0.34

.08

BASC-3 Hyperactivity

60.63 (13.41) 60.84 (14.04)

0.07

.02

Conners-3 Hyperactivity/Impulsivity

73.74 (17.09) 71.66 (15.43) -0.53

-.13

Conners-3 DSM ADHD Inattentive

73.33 (16.58) 76.10 (11.41)

0.70

.21

71.81 (16.20) 70.13 (15.51) -0.41

-.11

Conners-3 DSM ADHD
Hyperactive/Impulsive

Those with Medicaid insurance had marginally significantly higher mean Conners-3
DSM-5 ADHD Inattention problems as those with commercial insurance. Overall, Medicaid
insurance status was not related to parents’ report of symptom severity on behavior rating scales
measuring attention/inattention, hyperactivity/impulsivity, or ADHD problems; notably the
Conners-3 ADHD DSM-5 Inattention subscale may be more sensitive to socioeconomic factors
such as Medicaid status (see Table 13).
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Table 13
Comparing Mean Symptom Severity by Medicaid Insurance Status
Yes (n = 62)

No (n = 105)

Subscale

Mean (SD)

Mean (SD)

t

d

BASC-3 Attention Problems

64.76 (9.82)

64.33 (10.36)

-0.22

-.04

Conners-3 Inattention

79.29 (10.61) 75.94 (12.32)

-1.48

-.29

BASC-3 Hyperactivity

63.67 (13.94) 62.72 (13.98)

-0.36

-.07

Conners-3 Hyperactivity/Impulsivity

75.22 (14.68) 72.34 (16.24)

-0.95

-.18

Conners-3 DSM ADHD Inattentive

78.02 (11.58) 73.75 (13.02)

-1.67t

-.34

74.88 (14.23) 70.25 (16.34)

-1.45

-.30

Conners-3 DSM ADHD
Hyperactive/Impulsive
t

p < .10 level (2-tailed)

As can be seen in Table 14, those with a family history of ADHD were consistently
reported by their caregivers as having higher ADHD-related symptom severity, as indicated by
behavior rating scales, all with large effect sizes. Overall, family history of ADHD was a
marginally significant predictor of attention/inattention, and a significant predictor of
hyperactivity/impulsivity and ADHD problems.
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Table 14
Comparing Mean Symptom Severity by Genetic Heritability for ADHD
Yes (n = 87)

No (n = 82)

Subscale

Mean (SD)

Mean (SD)

t

d

BASC-3 Attention Problems

66.18 (8.98)

62.83 (10.92)

-1.83t

-.34

Conners-3 Inattention

79.00 (11.70)

75.52 (11.36)

-1.59

-.30

BASC-3 Hyperactivity

67.57 (13.66)

58.28 (12.56)

-3.84**

-.71

Conners-3 Hyperactivity/Impulsivity

76.00 (15.65)

70.27 (15.01)

-1.96*

-.37

Conners-3 DSM ADHD Inattentive

78.62 (12.01)

71.74 (12.13)

-2.80**

-.57

74.42 (15.61)

68.77 (15.28)

-1.80t

-.37

Conners-3 DSM ADHD
Hyperactive/Impulsive
t

p < .10 level (2-tailed)
*p < .05 level (2-tailed)
**p < .01 level (2-tailed)

Those children who were exposed to substances in-utero were consistently reported by
their caregivers as having higher ADHD-related symptom severity, as indicated by behavior
rating scales, all with large effect sizes. Overall, in-utero exposure to substances was
significantly related to problems with attention/inattention, hyperactivity/impulsivity, and ADHD
problems (see Table 15).
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Table 15
Comparing Mean Symptom Severity by Prenatal Exposure to Substances
Yes (n = 22)

No (n = 147)

Subscale

Mean (SD)

Mean (SD)

t

d

BASC-3 Attention Problems

69.08 (8.95)

64.02 (10.11)

-1.66t

-.51

Conners-3 Inattention

82.94 (8.71)

76.43 (11.82)

-2.10*

-.57

BASC-3 Hyperactivity

67.92 (15.84)

62.44 (13.62)

-1.30

-.40

Conners-3 Hyperactivity/Impulsivity

84.00 (10.77)

71.52 (15.60)

-3.99**

-.83

Conners-3 DSM ADHD Inattentive

81.93 (9.89)

74.55 (12.60)

-2.08*

-.60

81.93 (11.66)

70.27 (15.66)

-3.28**

-.77

Conners-3 DSM ADHD
Hyperactive/Impulsive
t

p < .10 level (2-tailed)
*p < .05 level (2-tailed)
**p < .01 level (2-tailed)

Symptom Mitigating Factors—Hypothesis 3. This hypothesis examined the
relationship between several factors hypothesized to mitigate ADHD symptoms (e.g., history of
intervention services, intact social skills, and intact adaptive skills) and symptom severity
(Hypotheses 3a-b). Both the global diagnosis of ADHD and the severity of ADHD symptoms as
reported by the parents were examined in relation to these symptom mitigating factors. T-tests
and chi-square tests were used to examine the relationship between symptom mitigating factors
and diagnostic status (yes/no ADHD), and the symptom severity as indicated by parent report of
attention problems/inattention (BASC-3 Attention Problems subscale; Conners-3 Inattention
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subscale), hyperactivity/impulsivity (BASC-3 Hyperactivity subscale; Conners-3
Hyperactivity/Impulsivity subscale), and ADHD problems (Conners-3 ADHD Inattentive
subscale; Conners-3 ADHD Combined subscale).
3a. Chi-square tests were run to examine the difference between expected and observed
symptom-mitigating factors (history of early intervention services, current social skills, and
adaptive skills) based on diagnostic status (yes/no ADHD). Per results in Table 16, there were no
significant differences found between expected and observed rates of symptom mitigating factors
by ADHD diagnostic status.
Table 16
Chi-Square Tests Examining Relationship Between Symptom Mitigating Factors and ADHD
Diagnostic Status
Participated in Early

Intact Social Skills

Intact Adaptive Skills

46:123

64:105

51:118

X2

1.15

.08

.50

p

.28

.77

.48

Cramer's V

.08

.02

.05

Intervention
n (Yes/No)

3b. T-tests were run to examine mean symptom severity as indicated by parents’ report
on behavior rating scales (BASC-3 Attention Problems, Conners-3 Inattention, BASC-3
Hyperactivity, Conners-3 Hyperactivity/Impulsivity, Conners-3 DSM ADHD Inattention,
Conners-3 DSM ADHD Hyperactive/Impulsive) based on symptom mitigating factors, including
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history of participation in early intervention services, intact social skills, and intact adaptive
skills.
In this sample, participation in early intervention services was not related to symptom
severity of attention/inattention, hyperactivity/impulsivity, or ADHD problems (see Table 17,
below).
Table 17
Comparing Mean Symptom Severity by History of Early Intervention Services
Yes (n = 46)

No (n = 123)

Subscale

Mean (SD)

Mean (SD)

t

d

BASC-3 Attention Problems

65.76 (9.73)

64.04 (10.23)

-0.84

-.17

Conners-3 Inattention

78.91 (9.66)

76.72 (12.35)

-0.91

-.19

BASC-3 Hyperactivity

65.50 (13.13) 61.99 (14.13)

-1.25

-.25

Conners-3 Hyperactivity/Impulsivity

76.21 (15.33) 72.09 (15.64)

-1.28

-.27

Conners-3 DSM ADHD Inattentive

78.03 (10.41) 74.58 (13.19)

-1.38

-.28

74.59 (15.65) 70.83 (15.62)

-11.09

-.24

Conners-3 DSM ADHD
Hyperactive/Impulsive

Those whose caregivers rated them as having intact social skills had significantly lower
mean BASC-3 Attention problems to those with below average social skills (see Table 18).
Those whose caregivers rated them as having intact social skills had significantly lower mean
BASC-3 Hyperactivity problems to those with below average social skills. Lower reports of
attention problems and hyperactivity, specifically on the BASC-3, were reported among those
children whose caregivers indicated that they had intact (average or better) social skills. Taken
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together, there is some evidence to suggest that intact social skills act as a buffer to caregivers’
reports of attention problems and hyperactivity, as indicated on the BASC-3; this same
relationship was not observed using the Conners-3 subscales.
Table 18
Comparing Mean Symptom Severity by Intact Social Skills
Yes (n = 64)

No (n = 105)

Mean (SD)

Mean (SD)

t

d

BASC-3 Attention Problems

62.58 (10.29)

66.85 (9.39)

2.34*

.43

Conners-3 Inattention

77.32 (12.76) 77.40 (11.07)

0.04

.01

BASC-3 Hyperactivity

60.09 (13.41) 66.44 (13.76)

2.53*

.47

Conners-3 Hyperactivity/Impulsivity

72.97 (16.24) 73.49 (15.35)

0.17

.03

Conners-3 DSM ADHD Inattentive

74.78 (12.59) 76.10 (12.49)

0.50

.11

72.14 (15.99) 71.82 (15.57)

-0.10

-.02

Subscale

Conners-3 DSM ADHD
Hyperactive/Impulsive
*p < .05 level (2-tailed)

Those whose caregivers rated them as having intact adaptive skills had significantly
lower mean BASC-3 Attention problems to those whose adaptive skills were below expectation
(see Table 19). Those whose caregivers rated them as having intact adaptive skills had
significantly lower mean BASC-3 Hyperactivity problems to those whose adaptive skills were
below expectation. Lower reports of attention problems and hyperactivity, specifically on the
BASC-3, were reported among those children whose caregivers indicated that they had intact
(average or better) adaptive skills.
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Table 19
Comparing Mean Symptom Severity by Intact Adaptive Skills
Yes (n = 51)

No (n = 118)

Subscale

Mean (SD)

Mean (SD)

t

d

BASC-3 Attention Problems

61.43 (9.70)

66.90 (9.78)

3.02**

.56

Conners-3 Inattention

75.74 (12.55) 77.80 (11.40)

0.75

.18

BASC-3 Hyperactivity

60.04 (13.46) 65.25 (13.87)

2.05*

.38

Conners-3 Hyperactivity/Impulsivity

71.65 (15.86) 73.75 (15.58)

0.57

.13

Conners-3 DSM ADHD Inattentive

72.83 (11.88) 76.45 (12.61)

1.22

.29

70.87 (16.20) 72.27 (15.57)

0.37

.09

Conners-3 DSM ADHD
Hyperactive/Impulsive
*p < .05 level (2-tailed)
**p < .01 level (2-tailed)

Additional Factors Impacting Relationship Between GA, Cumulative Risk and
Total Symptom Mitigating Factors, and Symptom Severity—Hypothesis 4. This study also
examined the additive predictive power of risk factors and symptom mitigating factors with GA
on ADHD symptom severity to clarify what amount of variance could be accounted for by each,
while controlling for current prescription for ADHD medication. Findings in Hypothesis 1
indicated that GA was marginally significantly related to symptom severity as measured by the
Conners-3. Findings in Hypothesis 2 indicated a relationship between several risk factors and
parent reported symptom severity: being a racial minority was marginally significantly related to
Inattention, Medicaid insurance status was marginally significantly related to DSM ADHD
Inattentive symptoms, family history of ADHD (i.e., genetic heritability) was marginally
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significantly related to parents’ report of Hyperactivity, and in-utero exposure was significantly
related to parents’ report across all subscales of the Conners-3. Findings in Hypothesis 3
indicated a significant relationship between symptom mitigating factors and symptom severity
only when using the BASC-3 as a measure. Taken together, multiple linear regression was
appropriate to examine the relationship between GA and risk factors on symptom severity as
measured by subscales on the Connners-3.
4a. A stepwise linear regression was conducted predicting Conners-3 Inattention
problems from current prescription for ADHD medication (control), GA, and racial minority
status. In Step 1, current medication accounted for 7% of the variance. In Step 2, adding GA
accounted for an additional 3%. In Step 3, being a racial minority accounted for an additional
3%. Overall, the regression was significant (see Table 20). Of the predictors investigated, current
prescription for ADHD medication and racial minority status were significant, and GA was
marginally significant. The total model accounted for 12.6% of the variance observed in
caregiver report of Inattention (Conners-3).
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Table 20
Predicting Conners-3 Inattention by GA and Racial Minority Status (n = 111)
b

SE

β

ΔR2

t

Step 1

0.07**

Current Prescription for ADHD Medication

6.55 2.34 0.26**

2.80
0.03t

Step 2
Current Prescription for ADHD Medication

6.65 2.32 0.26**

2.87

GA

0.86 0.47

-0.17t

-1.84

Step 3

0.03*

Current Prescription for ADHD Medication

6.75 2.29 0.27**

2.95

GA

-.84

.46

-.16t

-1.82

Racial Minority Status

4.10 2.11

.18*

1.95

t

p < .10 level (2-tailed)
*p < .05 level (2-tailed)
**p < .01 level (2-tailed)

A stepwise linear regression was conducted predicting Conners-3 DSM ADHD
Inattentive problems from current prescription for ADHD medication (control), GA, and
Medicaid status. In Step 1, current medication accounted for 6% of the variance. In Step 2,
adding GA accounted for an additional 3%. In Step 3, having Medicaid insurance accounted for
an additional 1%. Overall, the regression was significant (see Table 21). Of the predictors
investigated in the full model, only current prescription for ADHD medication was significant.
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Though GA and Medicaid status were marginally significantly related to inattention in bivariate
correlational analyses, it was current prescription for ADHD medication rather than GA or
Medicaid status that was found to account for significant variance in predicating Conners-3 DSM
ADHD Inattentive problems in the regression model. The total model accounted for 8.9% of the
variance observed in caregiver report of DSM ADHD Inattentive problems (Conners-3).
Table 21
Predicting Conners-3 DSM ADHD Inattentive Problems by GA and Medicaid Status (n = 96)
b

SE

β

t

Step 1

ΔR2
.06*

Current Prescription for ADHD Medication

6.29 2.70 .23*

2.33

Step 2

.03*

Current Prescription for ADHD Medication

6.24 2.68 .23*

2.33

GA

-.87

-1.60

.54

-.16

Step 3

.01*

Current Prescription for ADHD Medication

5.74 2.73 .21*

2.10

GA

-.75

.56

-.14

-1.36

Medicaid Status

2.51 2.62

.10

.96

*p < .05 level (2-tailed)

A stepwise linear regression was conducted predicting Conners-3 Hyperactivity from
current prescription for ADHD medication (control), GA, and family history of ADHD. Overall,
the regression was significant (see Table 22). Of the predictors investigated in the full model,
current prescription for ADHD medication and GA were significant. Though family history of
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ADHD was significantly related to parents’ report of hyperactivity on the Conner-3 in bivariate
correlational analyses, it was current prescription for ADHD medication and GA that accounted
for significant variance in the combined regression model. The total model accounted for 12.7%
of the variance observed in caregiver report of Hyperactivity (Conners-3).
Table 22
Predicting Conners-3 Hyperactivity/Impulsivity by GA and Family History of ADHD (n = 111)
b

SE

β

t

Step 1

ΔR2
.08**

Current Prescription for ADHD Medication

9.60

3.12 .28**

3.08

Step 2

.03**

Current Prescription for ADHD Medication

9.73

3.09 .29**

3.15

GA

-1.09

.62

-.16t

-1.74

Step 3

.02**

Current Prescription for ADHD Medication

9.04

3.10 .27**

2.92

GA

-1.09

.62

-.16t

-1.76

Family History of ADHD

4.62

2.84

.15

1.63

t

p < .10 level (2-tailed)
**p < .01 level (2-tailed)

Four regressions were run to examine how much variance was accounted for by in-utero
exposure to substances above that which was accounted for by current prescription for ADHD
medication (control) and GA, on symptom severity as measured by the subscales of the Conners3. All the regression models were significant (see Tables 23-26).
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A stepwise linear regression was conducted predicting Inattention from current
prescription for ADHD medication (control), GA, and in-utero exposure to any substances. In
step 1, current medication accounted for 7% of the variance. In step 2, adding GA accounted for
an additional 3%. In step 3, in-utero exposure to substances accounted for an additional 2%.
Overall, the regression was significant (see Table 23). Interestingly, GA was the only marginally
significant predictor of Inattention (in-utero exposure was not a significant predictor) after
controlling for current prescription for ADHD medication; in contrast, GA was not a significant
predictor in the full models predicting other dimensions of symptom severity such as
Hyperactivity or DSM ADHD problems (see Tables 24-26). The total model accounted for
11.1% of the variance observed in caregiver report of Inattention (Conners-3).
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Table 23
Predicting Conners-3 Inattention by GA and In-Utero Exposure to Substances (n = 111)
b

SE

β

t

Step 1

ΔR2
.07**

Current Prescription for ADHD Medication

6.55 2.34 .26**

2.80

Step 2

.03**

Current Prescription for ADHD Medication

6.65 2.32 .26**

2.87

GA

-.86

-.17t

-1.84

.47

Step 3

.02**

Current Prescription for ADHD Medication

5.87 2.38

.23*

2.47

GA

-.80

.47

-.16t

-1.71

In-utero Exposure to Substances

4.22 3.11

.13

1.36

t

p < .10 level (2-tailed)
*p < .05 level (2-tailed)
**p < .01 level (2-tailed)

In-utero exposure to substances accounted for significant variance in Conners-3
Hyperactivity/Impulsivity and DSM ADHD Hyperactive/Impulsive problems, above and beyond
what was accounted for by current prescription for ADHD medication. As previously mentioned,
GA was not a significant predictor of hyperactive symptom severity. Current prescription
medication and in-utero exposure were significant predictors of hyperactive symptom severity in
the full models, accounting for 14.8% and 14.5% of the variance in caregiver report of
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Hyperactivity/Impulsivity and DSM ADHD Hyperactive/Impulsive problems (see Tables 24 and
26, respectively).
Table 24
Predicting Conners-3 Hyperactivity/Impulsivity by GA and In-Utero Exposure to Substances (n =
111)
b

SE

β

t

Step 1
Current Prescription for ADHD Medication

.08**
9.60

3.12 .28**

3.08

Step 2

.03**

Current Prescription for ADHD Medication

9.73

3.09 .29**

3.15

GA

-1.09

.62

-.16t

-1.74

Step 3

t

.04**

Current Prescription for ADHD Medication

7.98

3.12

.24*

2.56

GA

-.94

.61

-.14

-1.54

In-utero Exposure to Substances

9.46

4.08

.21*

2.32

p < .10 level (2-tailed)
*p < .05 level (2-tailed)
**p < .01 level (2-tailed)

ΔR2
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Table 25
Predicting Conners-3 DSM ADHD Inattentive Problems by GA and In-Utero Exposure to
Substances (n = 98)
b

SE

β

t

Step 1
Current Prescription for ADHD Medication

.05*
5.73

2.66

.21*

2.15

Step 2

.03*

Current Prescription for ADHD Medication

5.74

2.63

.22*

2.18

GA

-.93

.54

-.17t

-1.73

Step 3

t

.02*

Current Prescription for ADHD Medication

4.81

2.69

.18t

1.79

GA

-.86

.54

-.16

-1.60

In-utero Exposure to Substances

5.48

3.58

.15

1.53

p < .10 level (2-tailed)
*p < .05 level (2-tailed)

ΔR2
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Table 26
Predicting Conners-3 DSM ADHD Hyperactive/Impulsive Problems by GA and In-Utero
Exposure to Substances (n = 98)
b

SE

β

t

Step 1

ΔR2
.09**

Current Prescription for ADHD Medication

10.09 3.26 .30**

3.10

Step 2

.02**

Current Prescription for ADHD Medication
GA

10.11 3.24 .30**
-.93

.66

-.14

3.12
-1.41

Step 3

.04**

Current Prescription for ADHD Medication

8.65

3.28

.26t

2.64

GA

-.82

.65

-.12

-1.25

In-utero Exposure to Substances

8.63

4.37

.19*

1.98

t

p < .10 level (2-tailed)
*p < .05 level (2-tailed)
**p < .01 level (2-tailed)
4b. Given the findings in Hypotheses 1-3, this hypothesis was no longer indicated, as
there was no significant relationship found between GA and symptom severity as measured by
the BASC-3 (Hypothesis 1), and symptom mitigating factors were only found to be related to the
BASC-3 (Hypothesis 3).
Neurocognitive Outcomes
The first four hypotheses were related to ADHD diagnostic status (determined by
neuropsychologist) and symptom severity (as indicated by caregiver report on behavior rating
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scales). The following hypotheses investigated outcomes related to neurocognitive dysfunction
theorized to underly the behavioral presentation associated with ADHD.
Relationship Between GA and Neurocognitive Functioning—Hypothesis 5. This
hypothesis examined the relationship between GA and neurocognitive functioning (Hypotheses
5a-c). T-tests, bivariate Pearson correlation coefficients, and ANOVA analyses were used to
examine the relationship between GA and overall intelligence g/IQ (WISC-V FSIQ), attention
(CPT-2/CPT-3 and WISC-V Digit Span Forward), working memory (WISC-V Digit Span
Backward and Digit Span Sequencing), executive functioning (D-KEFS TMT 4/Trails B, DKEFS CWIT 3/NEPSY Inhibition, D-KEFS CWIT 4/NEPSY Inhibition with Switching), and
processing speed (WISC-V PSI). Higher scores on measures of neurocognitive functioning
indicate greater functioning except for the CPT-2/CPT-3, for which higher scores indicate a
higher number of omissions (inattention) or commissions (impulsivity) and suggestive of greater
attention-related dysfunction.
5a. Bivariate Pearson correlations were run to examine the relationship between GA and
g/IQ, attention, working memory, executive functioning, and processing speed (Table 27). There
was a marginally significant relationship between GA and WISC-V FSIQ, r(167) = .14, p < .10.
All other measures of neurocognitive functioning showed a non-significant relationship with GA.
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Table 27
Bivariate Pearson Correlations Between GA and Neurocognitive Functioning Across Domains
Construct Measure

GA

g/IQ
WISC-V FSIQ

0.14t

CPT-2/CPT-3 Omissions

0.01

CPT-2/CPT-3 Commissions

-0.02

WISC-V DSF

0.11

Attention

Working Memory (WM)
WISC-V DSB

0.08

WISC-V DSS

0.01

Executive Functioning (EF)
Cognitive Flexibility (D-KEFS TMT4/Trails B, combined measures)

0.09

Inhibition (D-KEFS CWIT3/NEPSY I, combined measures)

0.05

Inhibition with Switching (D-KEFS CWIT4/NEPSY IS, combined

0.01

measures)
Processing Speed
WISC-V PSI
t

p < .10 level (2-tailed)

0.07
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5b. An independent samples t-test was used to examine mean differences in
neurocognitive performance between LAMP children and term-born children (see Table 28). All
measures of neurocognitive functioning indicated comparable mean performance between
LAMP children and term-born children.
5c. ANOVA analyses were planned to examine the relationship between GA group
(moderately preterm, late preterm, early term, and full-term) and g/IQ, attention, working
memory, executive functioning, and processing speed. Owing to the non-significant results in
Hypotheses 5a-b, an ANOVA was not indicated.
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Table 28
Comparing Mean Performance Across Neurocognitive Domains Between LAMP and Term-Born Children
LAMP

Term-Born

(n = 69)

(n = 100)

Mean (SD)

Mean (SD)

t

WISC-V FSIQ

91.65 (12.16)

94.56 (13.80)

1.41

CPT-2/CPT-3 Omissions

59.32 (13.91)

60.72 (15.47)

0.60

CPT-2/CPT-3 Commissions

52.87 (7.99)

53.40 (7.75)

0.43

WISC-V DSF

8.18 (2.53)

8.45 (2.43)

0.71

WISC-V DSB

8.31 (2.55)

8.54 (3.22)

0.52

WISC-V DSS

8.81 (2.89)

8.81 (3.14)

0.00

Construct Measure
g/IQ

Attention

Working Memory
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Table 28 continued
LAMP

Term-Born

(n = 69)

(n = 100)

Mean (SD)

Mean (SD)

t

8.28 (3.49)

8.32 (4.11)

0.06

Inhibition (D-KEFS CWIT3/NEPSY I, combined measures)

8.76 (3.33)

8.82 (3.47)

0.10

Inhibition with Switching (D-KEFS CWIT4/NEPSY IS, combined

9.30 (3.45)

9.78 (2.77)

0.83

93.16 (14.53)

95.64 (14.97)

1.07

Construct Measure

Executive Functioning
Cognitive Flexibility (D-KEFS TMT4/Trails B, combined
measures)

measures)
Processing Speed
WISC-V PSI
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Additional Factors Impacting Relationship Between GA and Neurocognitive
Functioning—Hypothesis 6. This hypothesis examined the relationship among identified risk
factors, symptom-mitigating factors, and neurocognitive functioning (Hypotheses 6a-6d).
Bivariate Pearson correlations and multiple linear regression analyses were used to analyze the
relationship between cumulative risk (sum of endorsed risk factors, including identification as a
racial minority, parents’ lack of higher level education, SES as indicated by Medicaid Insurance,
family history of ADHD, and in-utero exposure to substances) and total symptom mitigating
factors (sum of endorsed symptom mitigating factors, including participation in early
intervention services, intact social skills, intact adaptive skills) with g/IQ (WISC-V FSIQ),
attention (CPT-2/CPT-3 Omissions and Commissions, WISC-V DSF), working memory (WISCV DSB and DSS), executive functioning (D-KEFS TMT 4/Trails B, D-KEFS CWIT 3/NEPSY I,
D-KEFS CWIT 4/NEPSY IS), and speed of information processing (WISC-V PSI). In total, 10
bivariate correlations were run to test if cumulative risk is related to neurocognitive functioning,
and 10 for total mitigating factors.
6a. Bivariate correlational analysis were conducted between cumulative risk (race, SES,
parent educational level, genetic heritability, prenatal exposure) and performance across ADHDrelated neurocognitive domains (Table 29). There was a significant negative relationship
between overall g/IQ (WISC-V FSIQ) and cumulative risk, indicating higher endorsement of risk
factors was related to lower overall cognitive functioning. Regarding working memory, a
marginally significant negative relationship was found between WISC-V DSB and cumulative
risk, and a significant negative relationship between WISC-V DSS and cumulative risk (higher
endorsement of risk factors related to lower performance on tasks of working memory). Lastly,
the combined measure of cognitive flexibility was found to be significantly negatively related to
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cumulative risk, indicating higher endorsement of risk factors was related to lower executive
functioning. Most neurocognitive domains of interest showed some negative relationship to
cumulative risk (the exception being processing speed).
6b. Bivariate correlational analysis were conducted for total symptom-mitigating factors
(history of early intervention services, intact social skills, and intact adaptive skills) and
performance across ADHD-related neurocognitive domains (Table 29). Across all measures of
neurocognitive functioning, there was only one significant negative relationship found between
WISC-V DSF and total symptom mitigating factors. This could suggest that participation in early
intervention services and intact social and adaptive skills are paradoxically related to poorer
attentional functioning. Further analyses were needed to understand this relationship; t-test and
correlational analyses were used to look at the relationship between WISC-V DSF and each
symptom mitigating factor as a standalone variable.
A t-test was used to determine if average performance on WISC-V DSF was different
between those children who had received early intervention services, those with intact social
skills, and those with intact adaptive skills. Those who participated in early intervention services
had a lower average DSF (M = 7.37, SD = 2.30) than those who did not participate in early
intervention services (M = 8.70, SD = 2.43), t(166) = 3.22, p < .005, d = 2.40. There were no
significant differences in mean DSF based on intact social skills (yes/no) or adaptive skills
(yes/no). These results suggest that it is not total symptom mitigating factors that are inversely
related to poorer performance on a measure of brief attention (WISC-V DSF), but rather
participation in early intervention services that may predict differences in basic attentional
capacity.
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Table 29
Bivariate Pearson Correlations Between GA and Neurocognitive Functioning Across Domains
Total Symptom
Cumulative

Mitigating

Risk Score

Factors

WISC-V FSIQ

-.24**

-0.05

CPT-2/CPT-3 Omissions

0.11

0.09

CPT-2/CPT-3 Commissions

0.16t

0.00

WISC-V DSF

-0.11

-.18*

WISC-V DSB

-.18t

-0.05

WISC-V DSS

-.24t

0.00

-0.19*

-0.02

-0.10

-0.01

-0.11

-0.01

-0.05

-0.10

Construct Measure
g/IQ

Attention

Working Memory

Executive Functioning
Cognitive Flexibility (D-KEFS TMT4/Trails B,
combined measures)
Inhibition (D-KEFS CWIT3/NEPSY I, combined
measures)
Inhibition with Switching (D-KEFS
CWIT4/NEPSY IS, combined measures)
Processing Speed
WISC-V PSI

NEUROCOGNITION IN CHILDREN BORN LAMP

111

Table 29 continued
t

p < .10 level (2-tailed)
*p < 0.05 level (2-tailed)
**p < 0.01 level (2-tailed)

6c. GA was not found to be significantly correlated with neurocognitive outcomes (from
Hypothesis 5 findings), and, therefore, hierarchical regression analyses to examine the relative
contribution of cumulative risk with GA in predicting neurocognitive outcomes was no longer
indicated.
6d. Similarly, hierarchical regression analyses were no longer indicated to examine the
relative contribution of symptom mitigating factors with GA on neurocognitive outcomes.
Experimental Analyses
Moderation Models
Interaction Between GA and Additional Factors in Predicting Neurocognitive
Outcomes—Hypothesis 7. Moderation analyses were planned to examine the interaction effect
of GA with cumulative risk factors and with total symptom mitigating factors in predicting
neurocognitive outcomes. However, because there were no significant relationships between GA
and performance across ADHD-related neurocognitive domains, these moderation analyses were
no longer indicated.
Interaction Between GA and Birthweight in Predicting Neurocognitive Outcomes—
Hypothesis 8. Experimental analyses were conducted to examine the interaction effect of
birthweight and GA in predicting long-term behavioral and neurocognitive outcomes among
LAMP children and term-born children (Hypotheses 8a-b).
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8a. Moderation analyses were planned using birthweight (moderator) and GA in
predicting symptom severity. Results from Hypothesis 1 indicated a marginally significant
relationship between GA and symptom severity on the Conners-3 (Inattention subscale,
Hyperactivity/Impulsivity subscale, DSM ADHD Inattentive subscale, and DSM ADHD
Hyperactive/Impulsive subscale). Bivariate correlational analyses were run to look at the
relationship between birthweight and symptom severity on the Conners-3; results were nonsignificant, making further moderation analysis unnecessary (see Table 30).
Table 30
Correlations Between Birthweight and Symptom Severity as Indicated by Caregiver
Report on Conners-3, Controlling for Current Prescription for ADHD Medication
Partial Correlation
Conners-3 Inattention

-.08 [-.28, .13]

Conners-3 Hyperactivity/Impulsivity

-.08 [-.29, .13]

Conners-3 DSM ADHD Inattentive

-.10 [-.33, .13]

Conners-3 DSM ADHD Hyperactivity/Impulsivity

-.12 [-.34, .09]

8b. Moderation analyses were planned using birthweight (moderator) and gestational age
in neurocognitive performance across each domain (attention, working memory, executive
functioning, and processing speed). Results from Hypothesis 5 indicated a marginally significant
relationship between GA and g/IQ (WISC-V FSIQ). Bivariate correlational analyses were run to
look at the relationship between birthweight and FSIQ; there was a significant positive
relationship between birthweight and FSIQ, r(163) = .20, p < .01, indicating that moderation
analyses would be appropriate to look at the interaction between GA and birthweight in
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predicting FSIQ. Incidentally, there was also a marginally significant positive relationship
between birthweight and cognitive flexibility, r(136) = .16, p = .06 (Table 31).
Table 31
Bivariate Pearson Correlations Between Birthweight and Neurocognitive Functioning
Construct Measure

Birthweight

g/IQ
WISC-V FSIQ

.20*

CPT-2/CPT-3 Omissions

-.03

CPT-2/CPT-3 Commissions

-.01

WISC-V DSF

.09

Attention

Working Memory
WISC-V DSB

.05

WISC-V DSS

.07

Executive Functioning
Cognitive Flexibility (D-KEFS TMT4/Trails B, combined measures)

.16t

Inhibition (D-KEFS CWIT3/NEPSY I, combined measures)

.05

Inhibition with Switching (D-KEFS CWIT4/NEPSY IS, combined

.05

measures)
Processing Speed
WISC-V PSI
t

p < .10 level (2-tailed)

*p < 0.05 level (2-tailed)

.12
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Using mean-centered predictor variables, which were transformed into z scores with a
mean of 0 and SD of 1, moderation analysis found a significant interaction effect, b = 0.04, 95%
CI [0.00, 0.08], t = 1.96, p = .05, indicating that the relationship between GA and FSIQ is
moderated by birthweight (see Figure 1). Marginally significant transition points within the
observed range of the moderator were found using the Johnson-Neyman method; the boundaries
of the zone of marginal significance were -58.06 and 41.39. There was a marginally significant
negative relationship between birthweight and FSIQ, b = -2.29, 95% CI [-4.93, .34], t = -1.72, p
= 0.09, until the threshold for marginal significance ended at -58.06; as birthweight increased,
the relationship between birthweight and FSIQ remained non-significant until the value of
birthweight was great enough (41.39), b = 1.82, 95% CI [-.31, 3.96], t = 1.69, p = 0.09, at which
point there was a marginally significant positive relationship between birthweight and FSIQ.
Lower GA was related to lower birthweight, and children with this history were more likely to
exhibit a similar FSIQ. As GA increases, the impact of birthweight on FSIQ becomes more
apparent, with higher GA and higher birthweight predicting better neurocognitive outcomes, and
higher GA with lower birthweight predicting poorer outcomes at a marginally significant level.
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Figure 1
Birthweight Moderates Overall Neurocognitive Functioning as Measured by the WISC-V FSIQ
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Chapter 5: Discussion
Summary and Discussion of Major Findings
Premature birth rates in the United States are among the highest of all developed nations
(Howson et al., 2012). Of the estimated 15 million annual preterm births, more than 80% are
born LAMP (34-36 weeks and 32-33 weeks; Howson et al., 2012; Mayo Foundation for
Education and Research, 2017). It is well established in the literature that children born
premature are at increased risk for developmental delays and later neurodevelopmental disorders,
among them ADHD (Aylward, 2005, 2014; Vanderveen et al., 2009). However, much of the
existing literature has focused on those children who are born very or extremely preterm (< 31
weeks’ gestation) or examined outcomes among all prematurity groups, even though most
premature births are LAMP. Furthermore, by including those children who are born very or
extremely premature, who are more likely to have more complex early medical histories and
numerous comorbidities, the variance in neurocognitive outcomes includes outliers and medical
confounds, making it very difficult to hypothesize about expected neurocognitive outcomes
among most preterm children (LAMP). As such, the present study examined the question of
whether ADHD prevalence, ADHD symptom severity, and/or ADHD-related neurocognitive
deficits were higher among LAMP children than term-born children in a clinical sample of 8- to
12-year-old children. It is imperative that clinicians advise parents/caregivers regarding
prevention strategies given risk and intervention strategies at the earliest signs of deviation from
normative development; policy should similarly be informed by evidence-based best practice
standards for prevention and intervention, as preterm children may be at higher risk for worse
medical, academic, and socioemotional outcomes than their term-born peers.
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Given the research that has found premature children to be at two- to three-fold risk for
ADHD (American Psychiatric Association, 2013), it was hypothesized that this would remain
true in the LAMP subset and there would be a higher prevalence of ADHD among children born
LAMP than children who were term-born. ADHD diagnoses are given based on
reported/observed behavior across multiple settings (see Appendix A for full diagnostic criteria).
Behavior rating scales are very frequently used to get a standardized measure of social-emotional
behavioral functioning and establish if ADHD-related behaviors deviate from developmental
expectation to a clinically significant degree. Therefore, in addition to higher rates of ADHD, it
was predicted that LAMP children would also exhibit greater symptom severity in attention
problems/inattention, hyperactivity/impulsivity, and DSM-5 ADHD-related behaviors as reported
by their caregivers.
There are certain neuroanatomical and neurocognitive differences that would be expected
given those behavior patterns observed in ADHD (i.e., brain-behavior relationships). Brain
regions implicated in ADHD include the attention systems. In the case of ADHD, disruptions in
the attentional systems are evident in several regions and networks involving the prefrontal
cortex (PFC), anterior cingulate cortex, caudate, orbitofrontal cortex, cerebellum, frontal-striatal
network, the dorsal frontoparietal system, and the ventral frontoparietal system. Notably, the
PFC is the last area of the brain to reach maturation, though the infrastructure and networks
connected to and communicating with the PFC begin to develop in-utero; thus, disruption of the
gestational period in LAMP birth impacts early develop of the PFC networks (Willcutt, 2010),
and provides a neural foundational understanding of how preterm birth may operate as a risk
factor for and predictor of ADHD. Aligned with those neuroanatomical differences in ADHD,
there are expected neurocognitive deficits. In addition to accounting for IQ, ADHD evaluations
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should include assessment of attention, working memory, executive functioning, and speed of
information processing. As such, it was hypothesized that LAMP children would exhibit lower
overall neurocognitive performance (g/IQ), diminished attentional capacity, and poorer
performance on measures of working memory, executive functioning, and processing speed.
Brain-behavior relationships are further impacted by environmental factors and history
(biopsychosocial processes). There are known factors that impact the likelihood of a child
developing a neurodevelopmental disorder like ADHD. Though the primary focus of this study
was on the relationship between LAMP birth and ADHD-related outcomes, the present study
considered the ways in which other factors may impact or predict outcomes (multifinality and
equifinality). In addition to preterm birth, genetic heritability is a strong predictor of ADHD. Inutero exposure to substances, SES, lower parental educational achievement, and racial minority
status are all factors that also increase the risk for an ADHD diagnosis. It was hypothesized that
these risk factors interact with LAMP status resulting in an increased likelihood of developing
ADHD-related deficits by school age. In contrast, the literature also supports certain factors that
may decrease the likelihood of an ADHD diagnosis, or in other words, reduce the impact of
ADHD on day-to-day functioning. Participation in early intervention services is likely to have a
positive impact on development. For example, ADHD is often associated with poor social skills
and diminished adaptive skills, and children who have strength in these areas or have
participated in social skills groups may experience reduced ADHD-burden, including symptom
severity, reduced functional impairment, and lower rates of diagnosis. Collectively, participation
in early intervention services and intact social and adaptive skills were hypothesized to be
symptom mitigating factors that would be related to lower ADHD-related problems.
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ADHD Diagnosis
Inconsistent with the existing literature (Aylward, 2002; De Kieviet et al., 2012), the
current study did not support the hypothesis that there is a higher prevalence of ADHD among
those children who were born LAMP compared to children who were term-born; the mean GA
among those diagnosed with ADHD and not diagnosed with ADHD was comparable. This
finding was supported even when examining the various diagnostic categories for ADHD (see
Figure 2).

Figure 2
ADHD Diagnostic Outcomes

Note. LAMP (yellow) and term-born (green) children shown within total sample (blue) in
distribution of diagnostic subtypes.
Prevalence of ADHD in the current sample was much higher than in the general
population (76.9% versus 10.2%, respectively; Xu et al., 2018). The higher prevalence of ADHD
overall in this sample is understandable given that the data were collected in a clinical setting
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from a previously completed comprehensive neuropsychological evaluation. Patients in this
study were referred by providers and/or pre-authorized for the evaluation by their insurance
companies owing to established risk/probability. Were the sample to have been recruited and
collected from the general community and/or LAMP children and term-born children had been
followed and evaluated in a prospective study design, prevalence rates may have been more
consistent with community prevalence or the existing literature on ADHD in prematurity.
Additionally, the higher prevalence rate of ADHD in this sample may be explained by the
very high prevalence of other risk factors that were present in the sample and are summarized in
Table 6. The multitude of risk factors observed in this sample’s prenatal and perinatal history,
coupled with the high prevalence of ADHD in this sample, supports an etiology of ADHD that is
multifactorial, with contributions from genetic, environmental, and psychosocial factors. This
finding is well aligned with the theory of equifinality (Cicchetti & Rogosch, 1996).
There were additional sample characteristics that likely impacted diagnostic outcomes in
the present study. The present study’s racial demographics were as follows: 1.8% Asian, 25.4%
Black/African American, 59.8% White, 5.3% Latino/Hispanic, 5.3% Biracial/Mixed, and 2.4%
unreported. There has been a wave of public health research that evidences ways in which Black
people living in the United States have worse health outcomes as a direct consequence of
systemic and individual level racism. With over one quarter of the sample population identifying
as Black, and a cumulative 37.87% identifying as something other than White, this sample was
comprised of a significant racial minority population. In such a sample, the deleterious impact of
racism (overt, covert, microaggressions, systemic systems, inequality, injustice, within
generation and from a multigenerational perspective) and a plethora of associated health risks,
increases the overall risk for neurodevelopmental disorders including ADHD (Trent et al., 2019;
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Wright et al., 2020). Therefore, when considering race as a risk factor, it is important to
understand that identification as a racial minority functions as a proxy for other social conditions
(e.g., disparities in access to/quality of healthcare, exposure to racism, minority stress, etc.).
Similarly, SES (and proxies for SES such as limited parental educational achievement and
Medicaid status) is associated with a plethora of additional risk that can impact development
(e.g., disparities in access to/quality of healthcare, quality of education, additional
supports/resources, financial stress/housing insecurity/food insecurity, exposure to teratogens
and pollution, lower nutrition dietary options and limited food resources, etc.).
ADHD Symptom Severity via Behavior Rating Forms
The current study partially supported the hypothesis that caregivers of LAMP children
would report higher levels of ADHD symptomatology than caregivers of term-born children,
regardless of diagnostic status. After controlling for current prescription for ADHD medication, a
marginally significant relationship was found between GA and symptom severity as indicated by
parent report on the Conners-3, including the Inattention, Hyperactivity/Impulsivity, DSM
ADHD Inattentive, and the DSM ADHD Hyperactive/Impulsive subscales. Furthermore,
caregiver report of Inattention and Hyperactivity/Impulsivity (Conners-3) were found to be
marginally significantly higher among LAMP children than their term-born peers. Using GA as a
continuous variable, there was a clear and consistent relationship with symptom severity on the
Conners-3. When using subdivisions of GA, those that define LAMP and term-born children, the
relationship between LAMP status and symptom severity on the Conners-3 is somewhat less
apparent as it was not-significant for the DSM ADHD subscales. This suggests that the
relationship between time spent in gestation and behavioral outcomes at school-age may be
easier to see when using GA rather than gestational category.
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After controlling for current prescription for ADHD medication, there were marginally
significant differences observed between LAMP and term-born children on measures of
Inattention and Hyperactivity/Impulsivity specifically on the Conners-3, but not the BASC-3. To
better understand why that would be, it is worth considering which behaviors are included on
these measures. The follow items are included on the Conners-3 Inattention subscale: trouble
staying focused on one thing at a time, short attention span, avoids/dislikes things that take a lot
of effort and are not fun, trouble concentrating, doesn’t pay attention to details/makes careless
mistakes, trouble changing from one activity to another, inattentive/easily distracted, gets bored,
gives up easily on difficult tasks, and trouble keeping mind on work or play for long (Conners,
2008). No doubt, the items on this subscale capture those behaviors that would be expected in
disrupted attention networks. Items on the BASC-3 Attention Problems subscale include: pays
attention, organized, short attention span, listens to directions, listens carefully, easily distracted,
misses deadlines, pays attention when being spoken to, and has trouble concentrating (Reynolds
& Kamphaus, 2015). Examining these two scales qualitatively, the Conners-3 presents all the
behaviors as deficits with specific behavioral indicators (e.g., gives up easily on difficult tasks)
that directly map onto the DSM-5 criteria for Inattention (see Appendix A for the diagnostic
criteria for ADHD). In contrast, the BASC-3 words some behaviors positively (e.g., pays
attention, organized, etc.) that have no context for when these behaviors occur, and there are
several items on the BASC-3 Attention Problems subscale related to listening and receptive
language functioning, which may or may not reflect a child’s specific attentional difficulties.
Consequently, it may be the case that the BASC-3 is less sensitive to purely attention difficulties.
Items on the Conners-3 Hyperactivity/Impulsivity subscale include: fidgeting, blurts out
answers before the question has been completed, is constantly moving, excitable/impulsive, gets
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over-stimulated, acts as if driven by a motor, blurts out the first thing that comes to mind, has
difficulty waiting for his/her turn, runs or climbs when he/she is not supposed to, is noisy and
loud when playing or using free time, leaves seat when he/she should stay seated, fidgets or
squirms in seat, restless or overactive, and interrupts others. Most of these items provide concrete
behavioral anchors that can be observed by the reporting caregiver. Items included on the BASC3 Hyperactivity subscale: acts without thinking, is overly active, interrupts others when they are
speaking, has poor self-control, fiddles with things while at meals, is in constant motion, disrupts
other children’s activities, is unable to slow down, interrupts parents when they are talking on the
phone, acts out of control, and cannot wait to take turn (Reynolds & Kamphaus, 2015). There are
several items on this subscale that rely on caregivers’ interpretation of a child’s inner experience
or comparison to other children, rather than asking them to report on the presence of specific,
observable behaviors.
In sum, results of the present study suggest that the Conners-3 may be a more sensitive
measure when it comes to purely attentional constructs. This is consistent with the intention of
the Conners-3, which the manual describes as “a thorough and focused assessment of AttentionDeficit/Hyperactivity Disorder (ADHD) and its most common comorbid problems and disorders
in children and adolescents” (Conners, 2008, p. 1). The BASC-3, on the other hand, is intended
to assess a broad range of behaviors and emotions and was not specifically designed with a focus
on ADHD. However, it is also possible that there is questionnaire bias that explains the
difference in findings between the Conners-3 and Basc-3; many items on the BASC-3 include
more positive behaviors or attributes that may prime the caregiver to report more favorably.
Though the observed differences in symptom severity on the Conners-3 between LAMP
and term-born children were only marginally significant from a statistical perspective, the
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difference may be qualitatively or clinically meaningful. LAMP children may have subtle
differences in their attentional capacity, best captured by measures intended specifically to assess
dimensions related to ADHD such as the Conners-3. Without utilizing screening measures
specific to attentional capacity, LAMP children may fail to be identified either diagnostically
(ADHD) and/or via broad-based behavior and emotional screening, when they are exhibiting
attentional difficulties and would benefit from additional supports or intervention services.
An incidental finding of the present study was the impact of a current prescription for
ADHD medication on caregivers’ report of symptom severity, including aspects of inattention
and hyperactivity/impulsivity. There are several possible explanations for the relationship that
was found. Firstly, it’s possible that children exhibiting significant ADHD behaviors end up
being prescribed ADHD medication, and in turn, caregivers continue to report on those
behaviors that initially prompted/justified pharmacological management irrespective of the effect
medication has on their child’s ADHD symptoms. Another possibility is that participants in the
sample were recently prescribed medications for ADHD, and the pharmacological benefits were
not yet observed or present for the majority of the period in which caregivers were instructed to
report frequency of behavior. Accounting for duration of prescription status and giving
caregivers additional instruction while completing the behavior rating scale would help speak to
these points. Rating scales could explicitly instruct caregivers to rate their child’s behavior on or
off prescribed medication or allow caregivers to select whether they are rating their child’s
behavior on or off prescribed medication. It may also be the case that caregivers of children who
have been prescribed ADHD medications have been “primed” to report a higher frequency of
ADHD related behaviors; this may be to justify continued access to pharmacological
management, communicate their own distress in having a more challenging child, and/or
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emphasize the need for help to support and advocate for their child. Administering additional
measures of satisfaction with medication, parenting stress, or perceived support outside of the
home for the child would provide helpful additional information regarding the impact of an
ADHD medication prescription on caregiver report on behavior rating scales.
Risk Factors. The rating form manuals make recommendations regarding interpretative
consideration of other variables that may drive up symptom reporting. The present study also
considered the impact of other risk factors and potential symptom mitigating factors on
behavioral presentation in symptom severity. As previously mentioned, the Conners-3
Inattention subscale may have captured marginally significant variance attributable to racial
identity compared to other measures/subscales, and the DSM ADHD Inattentive problems
subscale may have captured marginally significant variance attributable to Medicaid insurance
status (proxy for lower SES). Regarding other risk factors, family history of ADHD and in-utero
exposure to substances were found to be related to all dimensions of attention, including
inattention and hyperactivity/impulsivity. Given that genetic heritability is the single strongest
predictor for ADHD, this finding was consistent with the literature (Biederman, 2005; Du Rietz
et al., 2018; Faraone et al., 2005; Franke et al., 2012; Leung & Hon, 2016). In the present
sample, 13% of children had in-utero exposure to substances (Table 3): 9.5% were exposed to
cigarettes, 3% were exposed to alcohol, 0.6% were exposed to narcotics, 1.8% were exposed to
stimulants, 1.2% were exposed to cannabis, 0.6% were suspected or exposed to something other,
and 0.6% were exposed to something unknown. The strong association between in-utero
exposure to substances and neurodevelopmental and behavioral problems that has been observed
in the literature (Menon, 2008; Tsang et al., 2016), was similarly found in this sample.
Furthermore, the high frequency of family history of ADHD (over 50%) combined with the high
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prevalence of in-utero exposure to substances may partially explain the high prevalence of
ADHD observed in this sample.
Symptom Mitigating Factors. The present study also examined potential symptom
mitigating factors. Prior research regarding longer term outcomes of early intervention services
have been mixed. Though early intervention has been found to improve early
neurodevelopmental skills (Blauw-Hospers et al., 2007), these benefits are no longer apparent in
later childhood (Vanderveen et al., 2009); results of the present study were consistent with the
latter, and there were no significant differences in ADHD-related symptom severity as indicated
by caregiver report on behavior rating scales between those who had and those who had not
received early intervention services. Previous studies have found that children with ADHD have
lower social and adaptive skills (Deboo & Prins, 2007; Lindblad et al., 2013; Staikova et al.,
2013). While there were no differences in social or adaptive skills between those diagnosed with
and without ADHD in the present study across rating scales, intact social and adaptive skills
were, as hypothesized, negatively related to attention problems and hyperactivity/impulsivity on
the BASC-3. As was previously discussed, the BASC-3 assesses a broad range of behaviors and
emotions, while the Conners-3 was created specifically to assess for attentional deficit.
Therefore, the BASC-3 may be more sensitive to strength-based variables and resilience. Though
social and adaptive skills may not differentiate those with ADHD from those without, building
these skills through prevention and/or intervention may provide a healthy behavioral outlet
(social interactions) and/or compensatory strategies (adaptive skills) that diminish the burden or
functional interferences of ADHD symptoms on overall presentation.
It is important to note that ADHD is an incredibly heterogenous neurodevelopmental
disorder. Though there are specific behavioral criteria, clinicians must rely on informant report to
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capture and/or quantify those behaviors and determine if they are in excess of what would be
expected given a child’s developmental level. Children may exhibit any combination of
behavioral features of ADHD, and/or the associated neurocognitive deficits, and still not receive
an ADHD diagnosis if there is no functional impairment. Furthermore, the threshold at which a
child’s behavior interferes with a child’s functioning across settings is highly individualized and
dependent on numerous interpersonal and environmental factors.
Informant report can be achieved via clinical interview, behavior rating scales, review of
school records that include qualitative descriptions of children’s behavior in the classroom, etc.
The present study utilized behavior rating forms completed by parents/caregivers and were then
able to integrate those standardized measures of behavior into the greater conceptualization and
diagnostic impressions. However, owing to the design of the study, and the setting wherein the
comprehensive neuropsychological evaluations took place, additional informant report (e.g.,
teacher) was not consistently provided nor included in analyses, though no doubt was included in
the clinician’s diagnostic impression and determination.
Neurocognitive Outcomes
The existing literature has found a relationship between LAMP and higher rates of
neurodevelopmental disability (Johnson et al., 2015) and cognitive impairments in overall
intellectual functioning, attention control, and inhibition (Cserjesi et al., 2012; Johnson et al.,
2015; Kerstjens, 2013). Results of the current study were consistent with the existing literature,
and a marginally significant relationship between GA and overall intellectual functioning
(WISC-V FSIQ) was found. No other measures of neurocognitive functioning were
significantly/marginally significantly related to GA. Variance within an individual’s
neurocognitive profile can be highly variable, especially among those measures that have an
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atypical distribution or more variable psychometric properties. The unique strengths and
weaknesses that exist in relationship to overall intellectual functioning may be washed out when
running analyses in a largescale dataset such as this. It is perhaps this reason that the only
marginally significant result between LAMP and neurocognitive abilities was in overall g/IQ,
and that relative strengths and weaknesses were not evident with the statistical analyses that were
utilized.
Children with lower GA are also more likely to have lower birthweight (Taylor, 2010).
Low birthweight has its own known associations with negative developmental and cognitive
outcomes (Mortensen et al., 2003). Results of the current study were consistent with the existing
literature: lower GA was related to lower birthweight, and children with younger GA and lower
birthweight were more likely to exhibit a similar FSIQ. As GA increases, the impact of
birthweight on FSIQ becomes more apparent, with higher GA and higher birthweight predicting
better neurocognitive outcomes, and higher GA with lower birthweight predicting poorer
outcomes at a marginally significant level. Taken together, it appears as though birthweight (low
and high) differentiates overall cognitive functioning (WISC-V FSIQ) for those children who
were born at a later GA and may play a less significant role in predicting outcomes among
children born earlier in the pregnancy.
This interaction between birthweight and gestational age among children born at/after the
32nd week of gestation in this sample suggests a few things. For those children born earliest
within this sample (moderately premature), g/IQ was comparable irrespective of birthweight.
However, for those children born later within this sample, lower birthweight predicted an FSIQ
that was nearly 10 standard score points below those with higher birthweight. Birthweight in the
last weeks of gestation differentiates overall neurocognitive outcomes, suggesting that lower
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birthweight may be capturing intrauterine growth restriction/fetal growth restriction or poorer
overall nutrition, which in turn predicts worse outcomes. For children born early term or term,
low birthweight remains a significant risk for later difficulties, despite the child having reached
the arbitrary cutoff of 37 weeks that defines term.
Cumulative Risk and Neurocognitive Outcomes. LAMP birth and ADHD share risk
factors, and many of those risk factors have a negative impact on neurocognitive functioning
(Howson et al., 2012; Shapiro-Mendoza & Lackritz, 2012). Therefore, the present study also
looked at the relationship between cumulative risk (i.e., number of risk factors endorsed:
minority status, lack of parental higher-level education, Medicaid status, genetic heritability, and
prenatal exposure to substances) and g/IQ, attention, working memory, executive functioning,
and processing speed. Consistent with prior literature, overall intellectual functioning, working
memory, and EF (specifically cognitive flexibility) were significantly related to cumulative risk.
It may be the case that the observed neurocognitive deficits associated with LAMP birth
reflect, at least in part, other risk factors associated with poorer neurodevelopmental outcomes
and why the present study did not find a significant relationship between GA and cognitive
functioning in specific domains. Though GA among LAMP children may not be a significant
predictor for neurocognitive outcomes, it is reasonable to expect that in a population with a
higher prevalence of risk factors such as the ones included in the present study (and including
both LAMP and term-born children), there would also be a higher rate of associated
neurocognitive weaknesses. The present study utilized data from patients presenting for clinical
concerns, pre-authorized by their insurance companies owing to identified risk to justify a
neuropsychological evaluation, and who reflected the diverse community in which the hospital
was located. It follows that this higher risk population would endorse a greater number of known
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risk factors, and that those risk factors would predict greater pathology including behavioral
challenges and neurocognitive weaknesses (equifinality).
Total Symptom Mitigating Factors and Neurocognitive Outcomes. The existing
literature has generally found that early intervention services have a positive proximal impact on
neurodevelopmental skills but does not exert a measurable impact on cognitive outcomes in later
childhood (Blauw-Hospers et al., 2007; Spittle et al., 2015; Vanderveen et al., 2009). Consistent
with this literature, results of the current study did not find a significant relationship between
total symptom mitigating factors (early intervention and intact social or adaptive skills) and
neurocognitive outcomes, with one exception: there was a significant negative relationship
between total symptom mitigating factors and a measure of brief attention. Specifically, it was
participation in early intervention services that predicted differential performance on this
measure (not having intact social or adaptive skills). It may be the case that children with more
significant delays warranting participation in Early On are a higher risk group within LAMP
children, and differences in attention capacity remain evident in later life, irrespective of
intervention efficacy. Additional research is needed to assess attention before and after
participation in interventions such as Early On to account for direction of effect.
Limitations
The current study addressed important gaps in the literature, specifically the use of
performance-based neuropsychological measures in addition to diagnostic status and behavior
rating scales to examine ADHD-related outcomes among a subset of children born premature—
LAMP. There were several significant limitations related to the study’s design, some of which
have been previously alluded to but will be discussed further. First, the study was crosssectional, and the data were pulled from patients who were seen during a specific window of
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time (2014-2020). The direction of influence between GA and behavioral and neurocognitive
outcomes by school-age is obscured by chronological variables and interim history. The present
study used certain risk and symptom mitigating factors available in the medical record, but very
likely missed other variables in the child’s history that were related to the measured outcomes; it
did not measure factors related to educational experience (e.g., type of school, quality of
curriculum, tutoring) or participation in intervention services over the age of 5 years, which
could certainly have impacted outcomes in the present study. A longitudinal design that follows
both term-born and LAMP children from birth through school-age, and can account for other
prevention, intervention, and learning experiences that happen during development, could
prospectively examine the relationship between GA and ADHD-related outcomes, while also
accounting for other variables that impact those outcomes.
The cross-sectional design also creates a de facto bias in that study participants (termborn and LAMP) were all taken from a clinical sample, where they had been pre-authorized for
neuropsychological evaluation owing to known risk. A longitudinal design that followed termborn controls from birth would capture a comparison group free of this type of bias. Specifically,
the term-born children would be recruited from birth, and not selected based on existing
behavioral or cognitive concerns or other identified risk factors.
The study design was retrospective, and the variables utilized were not selected for
research purposes. Risk factors were based on caregiver report on the patient history form and/or
during the clinical interview and dependent on caregivers’ memory or understanding about their
child’s early history. For example, the caregiver completing the form/interview may not have
been the gestational carrier, and may not have known or remembered substance use, medications
taken during pregnancy, or understood the difference between placenta abruptia and placenta

NEUROCOGNITION IN CHILDREN BORN LAMP

132

previa, and toxemia and preeclampsia. Had the risk factors been collected via comprehensive
review of the medical record for both gestational carrier and the child, as could be incorporated
in the design of a longitudinal study, a more accurate and comprehensive picture may have
emerged. Additionally, caregivers were not asked questions regarding household income or
perceived financial security. Rather, Medicaid insurance coverage and parents’ lack of higherlevel education were used as proxies for capturing dimensions of SES. Although these proxies
are frequently used for SES (Becker & Newsom, 2003; McLaughlin & Sheridan, 2016),
perceived financial security is a better measure in that it captures the individual’s psychological
response to their economic condition.
Symptom severity was measured using caregiver report on behavior rating scales and was
not determined by the clinician. As such, the symptom severity only captures one person’s
perspective, and reporters likely have variable experience working with other children at this age
as well as few observations of their child across settings. It would have been ideal to have
additional rating scales completed by teachers, who are able to compare a child’s
attention/inattention and hyperactivity/impulsivity to many other children of the same age and
attest to the child’s behavior in a structured environment (e.g., school setting outside the home).
Alternatively, clinician determination of symptom severity based on integration of parent,
teacher, and independent behavioral observation would have been very helpful in gaging
presentation across settings. However, the clinician would not provide symptom severity in this
way unless the child met criteria for and was given a diagnosis of ADHD. Either a standardized
behavior rating form that captures behaviors related to attention and hyperactivity, or coding
clinician observation in a clinical setting (e.g., coding behavioral observations), could be useful
in future research designs.
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There are notable limitations to analyses that use large neurocognitive datasets. Relative
strengths and weaknesses that are idiosyncratic to the individual patient are washed out when
running analyses that collapse performance across participants. When looking at a whole sample
of participants’ performance, the comparison is to the general population; within the context of
an individual neuropsychological evaluation, comparisons are made to both the general
population as well as within the profile to ascertain strengths and weaknesses. Consequently,
analyses such as those used in the present study may have failed to capture relative strengths and
weaknesses that could further illuminate the relationship between GA and neurocognitive
outcomes. Future studies may consider cluster analyses to capture strengths and weaknesses on a
larger scale (Allen & Goldstein, 2013).
Lastly, the COVID-19 pandemic impacted the process by which data was to be mined
and entered. There were office closures and furloughs, reduced patient volume, and hiring
freezes, which prevented the recruitment and training of additional research personnel. As such,
all data were pulled from the EMR, entered into the database, and checked by the same
researcher. Though the data were double checked and cleaned, the entirety of this process was
done by the same researcher, making the dataset vulnerable to inaccuracies. Further, it was
hoped the total sample would include 200 participants, with approximately 50 subjects for each
of the four LAMP and term-born categories. Given reduced patient volume, there were fewer
patient files for review, and the final sample included 17 moderately preterm children, 52 late
preterm children, 31 early term children, and 69 full-term children. The smaller N reduced the
power in the analyses, hence why a p-value of < .10 was utilized in the interpretation of the data.
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Clinical Implications and Future Directions
The current study provided evidence that LAMP children remain at risk for some poorer
neurocognitive outcomes, specifically overall intellectual functioning, than their term-born peers.
Furthermore, it is birthweight that appears to differentiate children at higher GAs, indicating
higher GA and higher birthweight result in better neurocognitive outcomes compared to higher
GA with lower birthweight predicting poorer outcomes. Moreover, it was children’s cumulative
risk (e.g., being a minority, low SES, genetic heritability, and prenatal exposure to substances)
that was found to be significantly related to deficits in working memory and executive
functioning—not GA. Lastly, two of the hypothesized symptom-mitigating factors (e.g.,
specifically intact social and adaptive functioning) were related to lower attention problems and
hyperactivity (BASC-3); conversely, participation in early intervention services was related to
lower performance on a measure of brief attention, suggesting that some delays and/or
difficulties in early childhood that warrant participation in Early On may still be evident in later
life. Taken together, these findings have implications for clinicians and policy makers who work
to improve outcomes for higher risk children.
Though future research is needed to better understand the relationship between GA and
ADHD-related behavioral and neuropsychological outcomes, the present study provides
preliminary evidence that those last weeks of the gestational period are meaningful in terms of
children’s neurocognitive development by school-age. However, risk and symptom mitigating
factors do appear to exert additional influence on cognitive outcomes, irrespective of GA,
suggesting that there is significant opportunity for prevention/intervention. Given the limitations
of the study design described above, it is very likely that there were additional variables that
impacted outcomes that were not captured. A prospective longitudinal design is necessary to
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better understand what factors predict better or worse outcomes for LAMP children, as well as
the plethora of risk factors (alone and in combination) that predict ADHD and ADHD-related
pathology irrespective of GA.
From a clinical perspective, findings of the present study apply to battery selection in
neuropsychological assessment. Results of this study suggest that the BASC-3 may be less
susceptible to demographic variables, specifically race and Medicaid status, which is an
important consideration especially in diverse settings and among higher risk communities.
Furthermore, the BASC-3 was able to capture a negative relationship between social and
adaptive skills and attention problems and hyperactivity/impulsivity. The present study provides
some evidence that the social skills necessary to create and maintain healthy peer relationships
and adaptive behavioral strategies minimize functional impairment of attention problems. The
Conners-3 has notable advantages over the BASC-3 in its sensitivity to those attention
differences (behavioral and cognitive) that differentiate LAMP children and higher risk children,
from term-born and lower risk children. Overall, the Conners-3 was more sensitive to GA, which
could be crucial in capturing more subtle deficits that have significant impact on day-to-day
functioning, even though these subtleties do not always translate to an ADHD diagnosis.
Clinicians should be mindful that the BASC-3 may be better at capturing strength, while the
Conners-3 may be better at capturing, specifically, attentional deficits.
Furthermore, clinicians working with higher risk children, including LAMP and those
with other known risk factors predictive of neurodevelopmental disorders such as ADHD, should
be recommending and advocating for patient access to early intervention, serial monitoring of
behavioral and neurocognitive functioning, and bolstering social and adaptive skills to support
development through middle childhood and potentially beyond. For example, clinicians working
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in NICUs with graduating LAMP children should provide psychoeducation to parents regarding
elevated risk and what to monitor for through their child’s development; well child visits and
other routine pediatric monitoring appointments are the perfect opportunity to provide updated
education regarding normative development and expectations, and query for those behaviors and
symptoms the child is specifically at risk for exhibiting.
Existing policy requires all states provide services to children from birth through 2 years
with documented developmental delay or an established condition documented from another
health or mental healthcare provider (Early On Michigan, 2018; IDEA, 1990). Though low
birthweight and ADHD are among those established conditions that warrant automatic eligibility
to Early On services, preterm birth has not been included (Early On Michigan, 2016). This is
problematic as ADHD is not likely to be diagnosed this early in development. Therefore, results
of the current study would support policy revision to allow children who are born preterm
(including LAMP) and/or low birthweight, be automatically granted access to state-based
enrichment services such as Early On.
The public education system provides services to children beginning at the age of 3 years.
Individualized education plans (IEPs) are available to children to ensure a free and appropriate
education, including school-based intervention services such as speech and language pathology
(SLP), occupational therapy (OT), physical therapy (PT), social work (SW), access to a resource
room, and additional behavioral supports that will help facilitate optimal development and
academic participation (FAPE; Petrovello & Sullivan, 2017). Section 504 of the Rehabilitation
Act of 1973, P.L. 93-112, further protects the educational rights of children who have a disability
and may be experiencing difficulties despite adequate grades and classroom participation but do
not otherwise qualify for services under an IEP. The current educational policy, therefore, serves
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to protect children once they exhibit deficits or hold a diagnosis. Results of the present study
suggest that LAMP children, who may be at risk for subtle hits to overall neurocognitive
functioning, may benefit from a lower threshold of inclusion to help redress this disadvantage. In
addition, policy should direct insurance companies to reimburse for auxiliary services, such as
those offered in school (OT, PT, SLP), on an outpatient basis so that LAMP children and other
high-risk children receive maximal supports as soon as they begin to fall behind their peers or
exhibit behavioral and/or cognitive deficits.
Future studies should seek to investigate other variables in a child’s history (e.g., events that
occur between birth and school-age including educational experiences, traumatic events,
participation in prevention/intervention, tutoring, extracurricular enrichment, medical events,
etc.) that may impact neurocognitive outcomes in middle childhood. Replication of the present
study should use additional measures/perspectives to capture children’s behavioral functioning
across settings. Being able to better capture a child’s own unique strengths and weaknesses (e.g.,
cluster analysis, coding to capture relative strengths and weaknesses, adjustment for individual
baseline), while accounting for other factors that impact neurocognitive development (e.g., risk
and protective), will help illuminate which factors best predict ADHD, attention, working
memory, EF, processing speed, and related behaviors.
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Appendix A: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Criteria for ADHD
DSM-5 Diagnostic Criteria: Attention-Deficit/Hyperactivity Disorder
A persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development, as characterized by six or more of the
following symptoms in (1) Inattention or (2) Hyperactivity/Impulsivity that have persisted for at least 6 months to a degree that is inconsistent with
developmental level and that negatively impacts directly on social and academic/occupational activities. Several symptoms were present prior to age 12-years
and are present in two or more settings. There is clear evidence that the symptoms interfere with, or reduce the quality of, social, academic, or occupational
functioning. The symptoms do no occur exclusively during the course of schizophrenia or another psychotic disorder and are not better explained by another
mental disorder.
(1) Inattention:
(2) Hyperactivity/Impulsivity:
Often fails to give close attention to details or makes careless mistakes in schoolwork, at
Often fidgets with or taps hands or feet or squirms in seat; often
work, or during other activities; often has difficulty sustaining attention in tasks or play
leaves seat in situations when remaining seated is expected; often
activities; often does not seem to listen when spoken to directly; often does not follow
runs about or climbs in situations where it is inappropriate; often
through on instructions and fails to finish schoolwork, chores, or duties in the workplace;
unable to play or engage in leisure activities quietly; is often “on
often has difficulty organizing tasks and activities; often avoids, dislikes or is reluctant to
the go,” acting as if “driven by a motor;” often talks excessively;
engage in tasks that require sustained mental effort; often loses things necessary for tasks
often blurts out an answer before a question has been completed’
or activities; is often easily distracted by extraneous stimuli; is often forgetful in daily
often has difficulty waiting his or her turn; often interrupts or
activities.
intrudes on others.
Specify whether:
314.01 (F90.2) Combined presentation: If both Criterion (1) and (2) are met for the past 6 months.
314.00 (F90.0) Predominantly inattentive presentation: If Criterion (1) is met but Criterion 2 is not met for the past 6 months.
314.01 (F90.1) Predominantly hyperactive/impulsive presentation: If Criterion (2) is met and Criterion (1) is not met for the past 6 months.
Specify if:
In partial remission: When full criteria were previously met, fewer than the full criteria have been met for the past 6 months, and the symptoms still result in
impairment in social, academic, or occupational functioning.
Specify current severity:
Mild: Few, if any, symptoms in excess of those required to make the diagnosis are present, and symptoms result in no more than minor impairments in social or
occupational functioning.
Moderate: Symptoms or functional impairment between “mild” and “severe” are present.
Severe: Many symptoms in excess of those required to make the diagnosis, or several symptoms that are particularly severe, are present, or the symptoms result
in marked impairment in social or occupational functioning.
Note. Adapted from the American Psychiatric Association (2013)
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Appendix C: Psychometrics of Measure Capturing g
Core
Domain
g

Measure
WISC-V
FSIQ

Core
Constructs
Intellectual
Quotient (IQ)

Note. Adapted from Wechsler (2014)

Brief Description

Age

Psychometrics

The FSIQ is composed of 10 subtests that assess
abilities across the domains of verbal
comprehension, visual spatial processing, fluid
reasoning, working memory, and processing
speed.

6:0 to
16:11

Reliability (.96 overall, and .96-.97 among
8- to 12-year-olds) and Validity (evidence
for validity based on test content, response
processes, internal structure, relations with
other variables and consequences of testing)
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Appendix D: Psychometrics of Neuropsychological Measures by Domain
Core
Domain
Attention

Working
Memory

Executive
Functioning

Construct(s)

Measure

Brief Description

Age

Psychometrics

Sustained
attention,
visual
inattention,
impulsivity,
vigilance

CPT-2/CPT-3
Omissions
and
Commissions

14-minute, 360-trial administration, child is
required to press the spacebar or wired mouse
button when any letter except “X” appears

8:0+

Reliability (median test-retest correlation
was r= .67, internal consistency, median
split-half reliability r=.92 for the norm
samples and r =.94 for the clinical samples)
and Validity (discriminative validity,
incremental validity including 88.4%
sensitivity, and 87.3%. specificity when
used with Conners-3 parent rating scale)

Brief attention

WISC-V
Digit Span
Forward

6:0 to
16:11

Reliability (.75-.85 across relevant age
range, overall mean r = .81, among ADHD
sample r = .82, test-retest r = .82)

Working
memory,
spatial
revisualization

WISC-V
Digit Span
Backward

6:0 to
16:11

Reliability (.75-.83 across relevant age
range, overall mean r = .80, among ADHD
sample r = .82, test-retest r = .76)

Working
memory,
auditory
acoustic
memory

WISC-V
Digit Span
Sequencing

6:0 to
16:11

Reliability (.76-.84 across relevant age
range, overall mean r = .82, among ADHD
sample r = .84, test-retest r = .79)

Cognitive
flexibility

D-KEFS
TMT 4

The child is read a sequence of numbers and recalls
the numbers in the same order, involving auditory
rehearsal and temporary storage. Each Digit Span
item is composed of two trials with the same span
length. There are at least
9 items for each task. Several
The child is read a sequence of numbers and recalls
the numbers in backwards order, which requires
working memory,
transformation of information, mental manipulation,
and may involve visuospatial imaging. Each Digit
Span item is composed of two trials with the same
span length. There are at least 9 items for each task.
The child is read a sequence of numbers and recalls
the numbers in sequential order, which requires
auditory acoustic memory and numerical reordering. Each Digit Span item is composed of two
trials with the same span length. There are at least 9
items for each task.
The child completes paper and pencil task,
connecting encircled numbers and letters in
alternating order by drawing connecting line.

8:0 to
89:11

Reliability (internal consistency, stability
coefficients, and alternate-form reliability)
and Validity (evidence provided in terms of
the sensitivity of the tests to measure
important areas of higher-level executive
functions and correlation studies)
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Cognitive
flexibility

Children’s
Trail Making
Test Part B

The child completes paper and pencil task,
connecting encircled numbers and letters in
alternating order by drawing connecting line.

7:0 to
13:11

Inhibition

D-KEFS
CWIT
Inhibition

The child is presented with color names (e.g., red,
green, blue) printed in a different-colored ink and
must state the color of the ink rather than reading
the word.

8:0 to
89:11

Inhibition

NEPSY
Inhibition
Condition

The child is presented with arrows pointing up or
down and must state the opposite direction of the
arrow rather than stating the indicated direction.

5:0 to
16:11

Inhibition and
cognitive
flexibility

D-KEFS
CWIT
Inhibition/
Switching

The child is presented with color names (e.g., red,
green, blue) printed in a different-colored ink and
must state the color of the ink rather than reading
the word; however, when the word is in a box, they
must read the word rather than say the ink color.

8:0 to
89:11

Inhibition and
cognitive
flexibility

NEPSY
Inhibition
Switching
Condition

The child is presented with black and white arrows
pointing up or down and must state the opposite
direction of the white arrows and the indicated
direction of the black arrows.

7:0 to
16:0

Speed of
information
processing,
graphomotor
speed and
visual
scanning

WISC-V PSI

Reliability (test-retest reliability coefficient
of .56 of children tested a total of three
times with 6-month intervals between
testing sessions, alternate-form reliability,
interrater reliability) and Validity (good
sensitivity, ecological validity)
Reliability (internal consistency, stability
coefficients, and alternate-form reliability)
and Validity (evidence provided in terms of
the sensitivity of the tests to measure
important areas of higher-level executive
functions and correlation studies)
Reliability (r=.86 average among 7- to 12year-olds, test-retest reliability=.64-.87, and
interscorer agreement=.98-.99) and Validity
(content, construct, concurrent)
Reliability (internal consistency, stability
coefficients, and alternate-form reliability)
and Validity (evidence provided in terms of
the sensitivity of the tests to measure
important areas of higher-level executive
functions and correlation studies)
Reliability (r=.87 average among 7- to 12year-olds, test-retest reliability=.73-.94, and
interscorer agreement=.98-.99) and Validity
(content, construct, concurrent)

The PSI is calculated based on performance on two 6:0 to Reliability (.88 overall, and .84-.88 across
subtests: coding and symbol search. Coding
16:0
8- to 12-year-olds) and Validity (r=.58
requires a child to use a key to copy symbols that
indicating moderate correlations between
correspond with simple geometric shapes or
coding and symbol search; evidence for
numbers. Symbol search requires the child to scan
validity based on test content, response
search groups and indicate whether target symbols
processes, internal structure, relations with
are present. Both are conducted under timed
other variables and consequences of testing)
constraints (2 minutes).
Note. Adapted from Conners (2014), Delis, Kaplan, & Kramer (2001), Korkman, Kirk, & Kemp (2007), Reitan & Wolfson (1985) and Wechsler (2014)
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Appendix E: Psychometrics of Behavioral Reports
Measure

Core Constructs; Relevant
Subscales
Hyperactivity, Attention
Problems; ADHD Probability
Index

Brief Description

Age

Psychometrics

Parent (137 items) and teacher (156
items) ratings on adaptive and problem
behaviors in the home, community, and
school settings.

6:00 to
11:11

Good to Excellent Reliability (alpha coefficients
.92-.97 parent and .92-.97 teacher, test-retest r=
.87-.92 parent and r= .77-.91 teacher, interrater
reliability r= .59-.75 parent and r= .37-.73
teacher) and Validity (convergent, construct,
content, criterion related)

Conners-3

Inattention, Hyperactivity/
Impulsivity

110-item parents and 115-item teacher
rating form to assess youth with
characteristics of ADHD

6:0 to
18:11

Reliability (Cronbach’s alpha .91 parent and .94
teacher, test-retest r= .85 parent and r= .85
teacher, interrater r= .81 parent and r= .73
teacher) and Validity (factorial validity adequate
for parents, slightly lower for teachers,
convergent, divergent, and discriminative
validity)

ABAS-3

Adaptive functioning (General
Adaptive Composite);
conceptual, social, and practical
domains

BASC Schoolaged

Comprehensive assessment of adaptive
5:0 to
Reliability (r=.96-.99, good internal consistency,
behavior; parent/caregiver completes the 21:11
test-retest reliability=.82, interrater
measure via self-report regarding the
reliability=.72) and Validity (evidence based on
child’s abilities across conceptual
item content, response process, internal structure,
(communication, functional academics,
internal consistency, age-group differences,
and self-direction), social (leisure and
intercorrelations among skill areas, factor
social skills), and practical (community
structure, correlations with other variables, and
use, home living, health and safety, and
sensitivity)
self-care) domains.
Note. Adapted from Achenbach & Rescorla (2000, 2001), Conners (2008), Gioia, Isquith, Guy, & Kenworthy (2015), Harrison & Oakland (2015), and Reynolds
& Kamphaus (2015)

